The isolation and purification of chemical constituents of 'Croton megalocarpus' Hutch husks by Danyaal, Mohammed
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Croton megalocarpus Hutch, husks, diterpenoids, 
thin-layer chromatography, cytotoxicity, tyrosinase inhibition 
 
 
The Isolation and Purification of Chemical Constituents of Croton mega-
locarpus Hutch Husks 
MSc by Research Thesis 
By 
Mohammed Danyaal 
 
School of Life Sciences. Pharmacy and Chemistry 
FACULTY OF SCIENCE, ENGINEERING AND COMPUTING 
 
2 
 
ACKNOWLEDGEMENTS 
 
I would like to thank my Lord Allah (SWT) for giving me the blessing and motivation to 
complete my MRES to the best of my ability I would like to thank a number of people 
that have helped me and became part of my amazing journey of the MRES. I firstly 
would like to thank Dr James Barker for giving me the opportunity to pursue a natural 
products project as I was inspired from my BSc final year project. I am grateful to Dr 
James Barker for being able to set up a good team of supervisors that were part of my 
journey. I would like to give a massive appreciation to Dr Sianne Schwikkard who was 
always hands down on my project and ensuring I receive the best support I can re-
ceive. Dr Sianne Schwikkard took the time to have meetings with me and making sure 
I am on the right track. Dr Sianne Schwikkard is also a very good motivator and reas-
suring me whenever I felt stuck. I would like to mention and thank Dr Lauren Mulcahy-
Ryan for allowing me to use the cell culture laboratory. Dr Ryan was reassuring and 
was hands on in making sure I was comfortable in the laboratory and was there if I 
needed anything. I would also like to give a massive thank you to Dr Moses Langat of 
the Royal Botanic Garden, Kew for allowing me to conduct the chemistry side of my 
project at the Kew Gardens. The team at Jodrell Laboratory, were very welcoming and 
kind and supported me throughout my time there. I am grateful for learning the different 
apparatus and analytical techniques such as NMR, HRMS and rotavapor. I would like 
to thank Dr Moses Langat for supervising me at Kew gardens and show my highest 
appreciation for also being hands on in my project. Dr Moses Langat has taught me a 
lot on the chemistry side of my project and was happy to help. A special thanks to Dr 
Tom Prescott at Kew gardens for being part of my research and helped me in the 
bioassays side of my project. I am very thankful for Dr Tom Prescott for taking his time 
out to participate in my project. I would like to acknowledge individuals that happily 
helped when I needed anything such as Dr Ian Farrell, Alex Fudger and Dr Ali Al-
Kinani. I would like to thank Alex Fudger for taking out his time to help me learn the 
cell culture techniques. He was very helpful and kind and reassuring. Also, I would like 
to give a big thank you to my family and friends for being there for me and supporting 
me. The motivation from family and friends has been exhilarating. A special thank you 
to my mother Feyaz Begum and my father Mohammed Talib for looking after me when 
I was sick. My parents love and affection enabled me to recover as fast as possible 
which led me to continue my MRES. I would like to show my dearest appreciation to 
3 
 
my friends especially Asim Latif who have supported me from BSc till MRES. I would 
like to thank Kingston University for providing me with unconditional support. Kingston 
University has done a lot for me and my research and the staff have been absolutely 
amazing. My time at Kingston University has been resourceful and will always hold a 
special place in my heart. Thank you, Kingston University.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
ABSTRACT 
Croton is a genus that is part of the Euphorbiaceae family. Croton is widely used in 
traditional medicine in a number of African countries such as Kenya, Tanzania, 
Uganda, Sudan, Mozambique and Zambia. Members of the Croton have been re-
ported to treat malaria, diabetes, intestinal worms, influenza and arthritis along with 
other conditions. However, Croton megalocarpus Hutch is a species that is predomi-
nately found in Kenya. C. megalocarpus is regularly processed in the Croton factory 
that is situated in Kenya. The company that processes the nuts of C. megalocarpus is 
named Eco Fuels Kenya. The by-products from C. megalocarpus seed oil extraction 
includes fruit husks from the de-husking process and seed cake resulting from cold 
pressing of the oil.  
The purpose of this study is to see whether the husks of C. megalocarpus possess 
interesting compounds and to determine the safety of these compounds for alternative 
use. Chemical constituents found in the husks of C. megalocarpus, and various ex-
tracts obtained from the husks, seeds and fruit cake were tested for their cytotoxic 
effects against FM-55 human melanoma cells and mushroom tyrosinase inhibition ef-
fects. Extracts were prepared using hexane, dichloromethane and methanol solvents.  
The hexane extract of the husks produced an oil that had a similar profile to the cold 
pressed C. megalocarpus seed oil, the dichloromethane extract mainly exhibited 
diterpenoids of the labdane, cembrane and kaurane classes of compounds whereas 
methanol extract was mainly sugars with traces of magnoflorine and trans-4-hydroxy-
N-methyl-L-proline. The dichloromethane (DCM) extract was chosen for further anal-
ysis including additional extracts such as ethyl acetate and dichloromethane extract of 
Croton vinegar oil and tested for cytotoxic and anti- melanogeni9c properties. 
Seven compounds were successfully isolated from the dichloromethane extract of the 
husks of C. megalocarpus and characterised using nuclear magnetic resonance 
(NMR), high resolution mass spectrometry (HRMS) and infrared spectroscopy (IR). 
The seven isolated compounds are: trans ozic acid, sartone A, epoxykaurane, 
epoxychiromodine, vanillin, (-)-(1S*,4S*,10R*)-1,4-dihydroxycembra-2E,7E,11Z-trien-
20,10-olide and (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 7E,11Z-trien-20,10-olide.  
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In this study, the ethyl acetate extract of croton vinegar oil exhibited a tyrosinase inhi-
bition of 59.33% at 20mM concentration. Epoxychiromodine exhibited an inhibition of 
26.82% at 20µg/ml and showed to have a higher inhibition rate than the other isolated 
compounds. The dichloromethane extract of the husks was shown to have a cell via-
bility of 45.62% (P<0.05) at 50µg/ml concentration. Sartone A was shown to have a 
cell viability of 86.08% (P<0.05) at 50µg/ml. The cytotoxicity and tyrosinase inhibition 
assay have helped determine the safety and effectiveness of the compounds and ex-
tracts that may play a vital role in skin care, skin lightening treatments and cancer 
treatment. 
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1. Introduction 
The World Health Organization (WHO) estimate that 80% of the world population uti-
lise native medicinal plants as a source of healthcare (Salatino et al., 2007). This is 
because of the constituents present within the plants that exhibit medicinal effects. 
Croton is a plant genus which is part of the Euphorbiaceae family. In general, Euphor-
biaceae species have been found to be either toxic or medicinal due to the chemical 
nature of their constituents. The Croton genus is a large sector of the Euphorbiaceae 
family containing of 1,300 species of shrubs, herbs and trees (Salatino et al., 2007). 
Phytochemistry of Croton has revealed the discovery of 399 novel compounds, includ-
ing 339 diterpenoids (Xu et al., 2018). Croton is found in different continents of the 
world such as Africa, Asia, South America and North and Central America.  
It has been reported that 39 species of Croton have been identified in Rio de Janeiro 
alone and they have been used to treat a variety of diseases including cancer (Salatino 
et al., 2007). Thorough examination of Croton has revealed it contains constituents 
that have biological effects, including compounds such as phorbol esters, clerodanes, 
labdanes and kaurane (Salatino et al., 2007). These chemical constituents are known 
as diterpenoids with a minimum 20-Carbon structure. Also, Croton has been reported 
to contain aromatic compounds and fatty acids (oil) (Salatino et al., 2007). In many 
inhabiting countries, diverse parts of Croton have been used to treat an array of com-
plications.  
A review by Salatino et al (Salatino et al., 2007) lists the studies conducted on the 
biological properties of different Croton species. In the West Indies, the bark of Croton 
eluteria Bennett has been used to treat various diseases such as fever, malaria, bron-
chitis and dysentery. In the Atlantic forest of southern Brazil, bark and leaf decoctions 
of Croton celtidifolius Baill have been found to treat leukaemia, ulcers and rheumatism. 
In Mexico, aerial parts of Croton arboreous Millsp are used to produce an anti-inflam-
matory drink to treat respiratory ailments. Also, in North America, Croton californicus 
Mull found in the Mojave Desert is used as a pain reliever, for rheumatism. This is 
made from powdered leaves of the plant.  
In Tanzania, the roots of Croton macrostachys Hochst. ex Rich is widely used as an 
anti-diabetic whilst the seeds of the tree are used as purgative in Somalia. In Thailand, 
the plant Croton kongensis Gagnep is used for medicine for dysmenorrhoea. In India, 
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diverse parts of Croton roxburghii NP Balakr are widely known to be used to treat 
snake poisoning, infertility, fever and wounds (Salatino et al., 2007). Croton has been 
shown to exhibit anti-inflammatory, antioxidant and antibacterial properties. However, 
very little work has been done on the anticancer effects of these species. A better 
understanding of Croton chemistry and its bioactivity could lead to novel compounds 
being discovered which may be useful in treating a variety of diseases. This study 
focuses on the chemistry and biological assays of the husks of Kenyan Croton mega-
locarpus Hutch. The chemistry of several Kenyan Croton plants has been reported, 
including the chemistry of Croton alienus (Nyawira Muchane, 2019) Croton dichoga-
mus (Aldhaher et al., 2017), Croton megalocarpoides (Ndunda et al., 2016) and Croton 
sylvaticus (Ndunda et al., 2015). These Kenyan Croton taxa have been reported to 
mainly yield diterpenoids.        
 
1.1.  Croton megalocarpus Hutch 
Croton megalocarpus Hutch is a species that has gained interest due to its diverse 
applications, such as biofuel, organic fertilizer and poultry feed. A company that utilises 
the processing of C. megalocarpus nuts is called Eco Fuels Kenya (EFK). Table 1 
taken from a review article by Maroyi (Maroyi, 2017) represents a diversity of diseases 
that are treated by C. megalocarpus, the part of the plant used and the countries that 
practice this approach. 
Diseases/Conditions Part of plant used Country practiced 
Malaria Bark or root decoction Kenya, Tanzania 
Pneumonia Bark or leaf decoction Kenya 
Arthritis Bark decoction Kenya 
Influenza Bark and leaf decoction Kenya 
Intestinal worms Bark or leaf decoction Kenya, Tanzania 
Induced labour Root decoction Uganda 
Diabetes Leaf decoction Kenya 
Dysentery Bark decoction Kenya 
Respiratory problems Leaf decoction Kenya 
Typhoid Bark and leaf decoction Kenya 
 
 
Table 1: The ethnomedicinal uses of C. megalocarpus in Africa 
http://www.prota4u.org/search.asp 
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EFK is a company that takes great interest in utilizing C. megalocarpus trees and 
transforming them for use as biofuel. This is due to the rise in air pollution that is 
caused by fossil fuel and therefore adds to global warming. Various studies have in-
vestigated the effects of fossil fuel diesel and biodiesel on the environment. A study 
by Kibet et al (Kibet et al., 2018) states fossil fuel diesel is known to produce high 
particulate matter, nitrogen oxides and greenhouse gases. The study also states that 
biodiesel blend of ~ 20% reduced about 15% in particulate matter, carbon monoxide 
and polyaromatic hydrocarbon combustion (Kibet et al., 2018).  
Climate change reporter David Kariuki (Kariuki, 2017) reports that biodiesel burns 
cleaner than fossil fuel diesel due to its engine lubricating effects and non-sulfuric con-
tent. The company aims to replace diesel with the Croton biofuel. The oil found inside 
the Croton is squeezed and put through a chemical process to convert it for suitability 
for use in cars. However, an report in The Guardian by Laura Secorun ( Secorun, 
2017) named “This is our future – Kenya’s croton tree touted as new biofuels crop” 
states that as Kenya usually import all their oil, some rural communities are unable to 
afford diesel for their water pumps and vehicle fuel.  
One advantage of Croton nuts biofuel is that it can be directly used in water pumps 
and agricultural machinery like tractors (except for cars). The benefits of this led the 
company to process 1000 tons of Croton nuts for biofuel production in 2016 and mo-
tivated local farmers to plant the Croton tree on the scale of 100,000 trees. This would 
become more affordable for the local communities and therefore generate a good rev-
enue. However, the company has identified the benefits of the by-products of the Cro-
ton plant such as the seedcake paste that is the end result of pressed Croton nuts. 
The seedcake paste is found to be high in protein levels and used as poultry feed for 
farmers.  
The husks of the Croton plant are found to be used for fertilisers of depleted soil. This 
is cost effective for the agricultural industry in Kenya. However, Eco Fuels face issues 
such as marketing and knowledge for the development and growth of Croton. There-
fore, this is deterring future investors, alongside the low oil price that is good for the 
consumers. By conducting a thorough investigation of Croton and its flexible use may 
interest future investment to carry out production of biofuels on a much larger scale. 
The research on Croton has focused mainly on various parts of the plant such as the 
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root, stem bark and leaves. Very little work has been done on the fruit husks of C. 
megalocarpus and therefore the husks may contain compounds that could possess 
properties of interest. The safety of the compounds found in the husks can be tested 
and validate the handling of C. megalocarpus for safety and toxicity. This project aims 
to provide recognition of the husks for the EFK. 
The Croton megalocarpus tree is mainly found in central and eastern Africa including 
Kenya, Mozambique, Tanzania, Congo and Zambia (Maroyi, 2017). It is able to grow 
up to 40m in height and reach a diameter of 120 cm (Figure 1). The bark of the tree 
is identified to be grey and the leaves of the tree are oval in shape (Maroyi, 2017). The 
tree is known to prefer light and well drained soils (Maroyi, 2017). Croton megalocar-
pus tree has many uses. The wood of the tree has been used in the construction 
industry for things like flooring, stools, mortars and plywood (Maroyi, 2017). The wood 
is also used for firewood and charcoal production (Maroyi, 2017).  
 
 
 
 
 
 
 
Figure 1: Croton megalocarpus leaves (left) and the tree (right) Courtesy of KEW-
Gardens library: http://epic.kew.org/index.htm 
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1.2. Traditional Use and Bioactivity of Croton Species and Its 
Isolates 
Studies have shown that the roots of C. megalocarpus is commonly used by people in 
Kenya as it has been shown to treat a variety of health complications such as malaria 
and gastric problems (Bussmann, 2006). However, the leaf decoction has been shown 
to treat pneumonia, diabetes and respiratory complications (Kokwaro, 2009) and the 
bark decoction has been used as an herbal infusion to treat fever, colds and coughs 
(Fratkin,1996). This would indicate that different parts of C. megalocarpus possess 
unique compounds that are able to treat different conditions. Studies have shown and 
demonstrated the isolation of phytochemical compounds found in C. megalocarpus 
leaves and stem bark such as tannins, alkaloids, flavonoids, reducing sugars, sterols, 
terpenoids and clerodane diterpenoids (Maroyi, 2017) as shown in Figure 2.  In Tan-
zania, the bark of the tree has been shown to treat diseases such as constipation, 
fever and malaria (Johns T et al., 1994). The medicinal use of C. megalocarpus varies 
in different regions of Africa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: General class of compounds isolated from C. megalocarpus 
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Diterpenoids are most commonly found in oceanic organisms, higher plants and fungi. 
The following are different types of diterpenoids: ent-kaurane, labdane, cembrane, 
clerodane, halimane and abietane (Figure 3). The research conducted on the Croton 
genus has shown the abundance of diterpenoids present. Diterpenoids have been re-
ported as the predominant class of compounds extracted from various Croton species. 
Diterpenoids are a class of compounds that consist of a 20-Carbon structure. The 
online Dictionary of Natural Products Edition 28.2 states that diterpenoids are derived 
from geranylgeranyl pyrophosphate which is the biosynthetic precursor of the diterpe-
noid class of compounds (Figure 3a) 
 
 
 
 
 
Figure 3: Different types of diterpenoids associated with Croton species 
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Figure 3a: Biosynthetic route of geranylgeranyl pyrophosphate (GGPP) the precursor of diterpe-
noids. (Chhonker et al., 2018) 
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Furthermore, there have been studies conducted on Croton phytochemical analysis. 
It has been speculated that studying the chemistry of Croton may provide a better 
understanding of potential medicinal use. A study by Aderogba et al (Aderogba et al., 
2013) found that the ethyl acetate crude leaf extract of Croton sylvaticus contained 
acetylcholinesterase inhibitory activity alongside with other isolated compounds. The 
article determines that crude extract, solvent fractions and isolated compounds had 
high acetylcholinesterase (AChE) activity. The isolated compounds 2′-(3″,4″-dihydrox-
yphenyl)-ethyl-4 hydroxybenzoate, quercetin and kaempferol showed an IC50 range 
against AChE from 60.7- 415.0 µg/mL while crude and solvent fractions IC50 ranged 
from 235.0 – 4695 µg/mL. These findings demonstrated the potential of the isolated 
compounds and crude extract of Croton sylvaticus for further evaluation in the treat-
ment of neurodegenerative disorders (Aderogba et al., 2013).  
On the other hand, another study conducted by Mulholland et al (Mulholland et al., 
2010) found that stem bark of Croton gratissimus contained cembranolides and was 
shown to have moderate activity against ovarian cancer and to treat malaria as it is 
used by traditional healers for this purpose. In this study, compounds (1) and (3) (Fig-
ure 4) was tested against PEO1 and PEO1TaxR (taxane resistant) ovarian cancer cell 
lines and were shown to have a lower potency than paclitaxel (chemotherapy drug 
used to treat ovarian cancer). However, after repeated attempts, both compounds (1) 
and (3) (Figure 4) had no significant effect on PEO1 ovarian cancer line cells. It was 
stated that the tubulin binding site of the compounds were different to paclitaxel and 
was not recognised by the MDR (multidrug resistance) transporter that was abundant 
in PEO1TaxR cells (Mulholland et al., 2010).  
The paper reported compounds that were isolated from the stem bark of C. gratissimus 
were four novel cembrane compounds (1, 2, 5, 6) (+)-[1R*,2S*,7S*,8S*,12R*]-7,8-
epoxy-2,12-cyclocembra-3E,10Z-dien-20,10-olide (1), (+)-[1R*,10R*]-cembra-
2E,4E,7E,11Z tetraen-20,10-olide (2), (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 
7E,11Z-trien-20,10-olide (5) and (−)-[1R*,4S*,10R*]-4-hydroxycembra-2E,7E,11Z-
trien-20,10-olide (6). These compounds were isolated from the hexane and DCM ex-
tract of the plant. However, Langat et al. (2011) reported 10 compounds isolated from 
the leaves of C. gratissimus including novel cembrane diterpenoids (3, 4, 7-14) (+)-
(10R*)-cembra- 1Z,3Z,7E,11Z,15-pentaen-20,10-olide (3), (+)-(1S*,4R*,8S*,10R*)-
1,4,8- trihydroxycembra-2E,6E,11Z-trien-20,10-olide (4),  (−)-(1S*,4S*,10R*)-1,4- 
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dihydroxycembra-2E,7E,11Z-trien-20,10-olide (7), (−)-(1R*,4R*,10R*)-4- methoxy-
cembra-2E,7E,11Z-trien-20,10-olide (8), (−)-(1S*,4R*,10R*)-1-hydroxy-4- methoxy-
cembra-2E,7E,11Z-trien-20,10-olide (9), (−)-(1S*,4S*,10R*)-1,4- dihydroxycembra-
2E,7E,11Z-trien-20,10-olide (10), (+)-(1S*,4S*,7R*,10R*)-1,4,7- trihydroxycembra-
2E,8(19),11Z-trien-20,10-olide (11), (−)-(1S*,4S*,7S*,10R*)-1,4,7-trihydroxycembra-
2E,8(19),11Z-trien-20,10-olide (12), (+)-(10R*)-cembra- 1E,3E,7E,11Z,16-pentaen-
20,10-olide (13) and (+)-(5R*,10R*)-5-methoxycembra- 1E,3E,7E,11Z,15-pentaen-
20,10-olide (14).  Also, α glutinol (15), lupeol (16) and 4 (15)-eudesmene-1b,6a-diol 
(17) were isolated (Mulholland et al., 2010). Compounds were identified and charac-
terised using 13C NMR, 1H NMR and Infrared spectroscopy (IR). Figure 4 represents 
the compounds isolated from C. gratissimus.  
Figure 4: Compounds isolated from stem bark and leaves of C. gratissimus  
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A review by Alfred Maroyi. (Maroyi, 2017) reported the extraction and isolation of com-
pounds from the stem bark of C. megalocarpus conducted by Addae-Mensah et al 
(Addae-Mensah et al. 1992). In this study, a range of classes of compounds were 
successfully extracted and isolated. Two clerodane diterpenoids chiromodine (18) and 
epoxychiromodine (19), four triterpenoids lupeol (16), 3β-acetoacetyl lupeol (20) and 
ferulic acid ester derivatives (21-23), acetyl aleuritolic acid (24) and betulin (25) were 
isolated from stem bark of C. megalocarpus (Maroyi. 2017) as shown in Figure 5. 
Maroyi (Maroyi, 2017) also reported the range of impressive properties that C. mega-
locarpus was found to contain such as: anti-inflammatory, antifungal, healing, antibac-
terial, toxicity, molluscidal and antinociceptive activities. These properties raise great 
interest in testing C. megalocarpus for medicinal uses. 
 
 
A study by Alqahtani (Alqahtani, 2015) analysed compounds that have been extracted 
from the root of the C. megalocarpus plant. In a previous study by Addae-Mensah et 
al (Addae-Mensah et al., 1992) the stem bark of C. megalocarpus was studied and 
had revealed two clerodane diterpenoids chiromodine (18) and epoxychiromodine (19) 
and 4 triterpenoids lupeol (16), 3β-acetoacetyl lupeol (20) and ferulic acid ester deriv-
atives (21-23), acetyl aleuritolic acid (24) and betulin (25). However, Alqahtani 
((Alqahtani, 2015) analysed the root of C. megalocarpus to see any comparison of 
Figure 5: Compounds isolated from stem bark of C. megalocarpus.  
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compounds found in stem bark and root of the plant. The dichloromethane/methanol 
root extract yielded the following compounds: 6 clerodane diterpenoids 3-keto-15,16-
epoxy-13(16),14-entclerodadien- 17,12S-olide (crotonolide E) (26), 15,16-epoxy-3,4-
dihydroxy-13(16),14-entclerodadien-17,12S-olide (furocrotinsulolide A) (27), 
3β,4β:15,16-diepoxy-13(16),14-entclerodadien-17,12S-olide (28), epoxychiromodine 
(19), 3β,4β:15,16-diepoxy-13(16),14-entclerodadiene (29), trans-annonene (30), 
triterpenoid lupeol (16), halimane crotohalimaneic acid (31), two abietane 7,13-abi-
etadien-2-one (32) and 7,13-abietadien-2-ol (33). Therefore, it transpires that more 
compounds were isolated from the root of C. megalocarpus than the stem bark. The 
clerodane diterpenoids have been reported previously in Croton genus as stated by 
Alqahtani (Alqahtani, 2015). Figure 6 represents compounds 26-33. 
 
Figure 6: Compounds isolated from dichloromethane/methanol extract of the root of C. megalocarpus by 
Alqahtani (2015).  
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Moreover, anticancer screening of NCI60 human tumour cell lines was conducted on 
selected compounds by Alqahtani (Alqahtani, 2015). The compounds isolated from C. 
megalocarpus and selected for anticancer screening were compounds (19) (Figure 
5), 26-29 (Figure 6) and 31-33 (Figure 6). The methodology required 60 different hu-
man tumour cancer cell lines to be tested in two phases: phase 1 single dose injection 
of 10µM and phase 2 was testing compound against cancer cell line at a concentration 
of 5 µM (Alqahtani, 2015). Phase 2 was only possible for compounds that showed 
interesting cancer growth inhibition at phase 1. It was reported that all diterpenoids 
tested had no significant effect on the NCI60 cancer cell lines at a single dose of 10µM. 
In addition to the anti-cancer activities of diterpenoids, a paper by Jian et al (Jian et 
al., 2018) reported the sub-types of diterpenoids that had a positive effect on several 
cancer lines. In this study, 24 diterpenoids were successfully extracted from Euphorbia 
fischeriana a plant that is known for treating cancer, edema and tuberculosis (Jian et 
al., 2018). Diterpenoids isolated from Euphorbia fischeriana consisted of six ent-abi-
etane jolkinolide B (34), jolkinolide A (35), 17-hydroxyjolkinolide B (36), 17-ace-
toxyjolkinolide B (37), euphorin E (38), euphorin H (39), yuexiandajisu E (40), three 
tigliane prostratin (41), 13-O-acetylphorbo (42), 12-deoxyphorbol 13-palmitate (43), 
daphnane langduin A (44), four ingenane ingenol-6,7-epoxy3-tetradecanoate (45), in-
genol-3-myristinate (46), ingenol 3-palmitate (47), ingenol-20-myristinate (48), four 
ent-atisane ent-1β,3β,16β, 17-tetrahydroxyatisane (49), ent-1β,3α,16β,17-tetrahy-
droxyatisane (50), ent-3β-hydroxyatis-16-ene-2,14-dione (51), 19-O-β-D-glucopyra-
nosyl-ent-atis-16-ene-3,14-dione (52), three ent-rosane euphorin C (53), ebractenoid 
C (54), ebractenoid F (55), ent-kaurane ent-kaurane-3-oxo-16β, 17-acetonide (56) and 
lathyrane jolkinol A (57) (Jian et al., 2018) as seen in Figure 7.  
The study discovered that four ent-abietane, three ingenane, two ent-atisane, three 
ent-rosane and lathyrane had inhibitory action of cell proliferation of human breast 
cancer MCF-7 cancer cell line (Jian et al., 2018). This was due to the direct disruption 
of mammosphere formation in MCF-7 cancer cells. However, ent-kaurane-3-oxo-16β- 
17-acetonide was discovered to have inhibited cell proliferation of liver cancer cell line 
Hep-3B. The results of these diterpenoids seem promising for further analysis as they 
exhibit potential for development. The classes of compounds extracted by Alqahtani 
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(Alqahtani, 2015) have been found in the root of C. megalocarpus and therefore, would 
be interesting to compare any similarity or new compounds in C. megalocarpus husks. 
 
Figure 7: Compounds isolated from Euphorbia fischeriana by Jian et al. (2018).  
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1.3. Commercial Use of C. megalocarpus 
In agriculture, a report by Rik Thijssen in the book “Domestication and Commerciali-
zation of Non-timber Forest Products in Agroforestry Systems” (Leakey, 1996) states 
that the seed of Croton megalocarpus has inspired farmers of Kenya to use the Croton 
seeds contained within the plant for poultry feeding. The article states that the seeds 
contain a large amount of oil and protein in the ratio of 32:18. However, chickens have 
been fed Croton megalocarpus seeds which has shown no adverse effects and even 
saved food costs of farmers. This breakthrough has reformed the agricultural industry 
in Kenya as the seed has shown to be one example of food benefit. Moreover, whilst 
the nutritious elements of the seed have benefited agricultural purposes, the seedcake 
has also been used for production of biofuels.  
A study by Kafuku et al (Kufaku et al., 2010) identified the use of biodiesel which was 
derived from the seed oil of Croton megalocarpus. The study had aimed to create and 
utilise non- edible oil feedstock such as C. megalocarpus oil to produce biofuel. Cur-
rently, biodiesel is produced from edible oil feedstock such as vegetable oil and is 
affecting the food industry and may increase food price (Kafuku et al., 2010). This is 
because vegetable oil is a worldwide used oil and a large amount of vegetable oil 
crops is used for production of biodiesel. In the world today, it is estimated that 1.4 
billion cars are on the road. Therefore, processing a large amount of edible oil means 
less edible oil for the food industry and therefore the price of oil may increase. Crops 
that contain non-edible oils such as Croton megalocarpus can be produced in large 
quantities and processed for production of biofuels and replace the use of edible oil 
feedstock (Kufaku et al., 2010). The advantage of using edible oil for livestock such 
as sunflower oil is an easy and simple transesterification due to their lower free fatty 
acids (Kafuku et al., 2010). The study went on to illustrate and explore how a one-step 
transesterification is required to convert the seed oil of the Croton megalocarpus into 
fatty acid methyl esters (Kafuku et al., 2010). Also, the report had highlighted the key 
parameters that determined the efficiency production of biofuel such as: catalyst con-
centration, methanol to oil ratio, reaction temperature, agitation speed and reaction 
time (Kafuku et al., 2010). 
A study by Wu et al (Wu et al., 2012) investigated the use of C. megalocarpus biofuel 
for an alternative sector. The study goes on to describe the lack of electricity in sub-
Saharan Africa for home owners as it is an under developed region. This makes it 
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difficult for the people to be able to run household operations that require electricity, 
heat, light and water. The study by Wu et al (Wu et al., 2012) discovered the direct 
use of C. megalocarpus oil (CMO) in a 6.5 kWe micro-trigeneration prototype a ma-
chine that is able to distribute energy and electricity through a sustainable and cleaner 
source. This study showed that direct use of CMO reduces the carbon footprint com-
pared to the transesterification process of the conversion of CMO into biofuel (Wu et 
al., 2012). The results confirm that pure CMO had produced maximum power of 6.5 
kWe and around 13 kW heating output (Wu et al., 2013). This changed the view of the 
potential of C. megalocarpus as its further application of being able to generate power 
for a region in sub-Saharan Africa and this has the potential to help reduce poverty. 
Moreover, a study by Kibet et al (Kibet et al., 2018) also stated how biodiesel is a 
cleaner alternative as the particulates emitted are reduced from using C. megalocar-
pus biodiesel oil compared to petroleum diesel. 
 
1.4. Tyrosinase 
As stated by a review article by Maroyi (Maroyi, 2017), C. megalocarpus is used for 
wound healing and possesses anti-inflammatory, antifungal and antioxidant proper-
ties. The use of C. megalocarpus for treating skin conditions requires prior safety 
checks as compounds and chemicals within C. megalocarpus could be toxic. The po-
tential of C. megalocarpus being used to treat skin conditions opens a sizeable market 
for the cosmetic and beauty industry as it may be cost effective and more effective 
than products currently being used today. Skin lightening or skin bleaching is a treat-
ment plan used and contains chemical constituents’ corticosteroids, hydroquinone, 
mercury and other skin lightening agents (Yusuf et al., 2019).  
The purpose of skin lightening is the treatment of pigment disorders such as melasma 
and enrichment of the skin in terms of colorization. Since tyrosinase is a key enzyme 
in the production of melanin, tyrosinase is used as an effective platform for discovering 
new ways to administer compounds with fewer adverse effects (Chatatikun et al., 
2017). It has been reported that adverse effects of skin lightening agents include the 
following complications; acne vulgaris, hypertrichosis, perioral dermatitis, dischromias 
and ochronosis (Yusuf et al., 2019). This is why agents such as hydroquinone are 
administered in small amounts ranging from 2-5% concentration. Skin lightening 
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agents have been recognised as a potential health threat which has motivated a large 
number of countries to ban skin lightening products such as Ghana, Rwanda, South 
Africa and Sudan (Yusuf et al., 2019). Therefore, it comes to interest on seeing the 
effect of compound of husks of C. megalocarpus against tyrosinase. The potential of 
compounds being able to inhibit tyrosinase may provide alternative treatment to the 
skin lightening technique being used today. The action of hydroquinone is shown in 
Figure 8.  
 
Tyrosinase plays an important role with respect to skin cosmetics as testing the bio-
activity of tyrosinase may introduce new applications for the cosmetic industry. In the 
cosmetic industry today in Africa, skin lightening practices are very common. Hydro-
quinone (HQ) is used mainly to treat skin conditions such as hyperpigmentation, freck-
les, and melasma (Shin et al., 2014). The ability for HQ to strongly inhibit tyrosinase 
thus reducing hyperpigmentation has enabled it to be used as an effective treatment. 
However, it can also be noted that whilst HQ is shown to be effective, it has also been 
Figure 8: The action of hydroquinone inhibiting tyrosinase. This results in decreased 
production of dopaquinone. Therefore, this reduces melanin pigments produced for skin 
lightening treatment. Figure 8 was illustrated from http://www.becarre-natural.com/lighten-
ing.php 
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shown to cause cancer and ochronosis. According to a survey study by Dlova et al 
(Dlova et al., 2015), six hundred women aged 18-70 years were given a questionnaire 
on whether they use skin lightening products. The results showed that 32.7% reported 
using skin lightening products. Of the 32.7% that use skin lightening products, 66.7% 
said for skin problems and 33.3% for skin lightening. Therefore, skin lightening prod-
ucts have influenced repeated use in South African women. HQ is toxic and so testing 
the safety of compounds of husks of C. megalocarpus may provide a new application 
as an HQ replacement treatment. Therefore, having a compound that has low toxicity 
and have the ability to inhibit tyrosinase in the same manner as HQ may be of interest. 
 
A study by Chatatikun et al (Chatatikun et al., 2017) investigated the anti- melanogenic 
effect of the ethanolic extracts of Croton roxburghii (CRE) and Croton sublyratus 
(CSE) leaves. The study states that both CRE and CSE are known for their ability to 
be used for medicinal purposes and treatments such as skin diseases, wounds, fever 
and scabies (Chatatikun et al., 2017). However, Chataikun et al (Chatatikun et al., 
2017) also stated that no known reports have been published on any anti-melanogenic 
effects of extract of CRE and CSE. Similar properties are included with C. megalocar-
pus which is also part of the Euphorbiceae family. The toxicity of CRE and CSE were 
tested against α- melanocyte stimulating hormone (α-MSH) B16F10 mouse melanoma 
cells and showed to be non-toxic (Chatatikun et al., 2017). The study conducted a 
tyrosinase inhibition assay to see the quantity of both CRE and CSE that is able to 
inhibit the enzyme from converting L-DOPA to melanin. Kojic acid was used as a pos-
itive control.  
The study found that tyrosinase activity had lowered dramatically with 117.16% at 
50µg/ml and 159.33% inhibition at 100µg/ml for both CRE and CSE (Chatatikun et al., 
2017). Kojic acid had inhibited tyrosinase at 150% at a concentration of 250µg/ml. The 
results also show that both CRE and CSE lower tyrosinase activity at lower concen-
trations of 6.25-50µg/ml as opposed to kojic acid at 250µmg/ml. These findings show 
much promise for tyrosinase inhibition of C. megalocarpus as CRE and CSE have not 
previously been reported for anti- melanogenic effects. Therefore, C. megalocarpus 
can be considered for future development in cosmetics and skin care if chemical con-
stituents are found to be non-toxic and able to inhibit tyrosinase (the enzyme respon-
sible for melanin production) for skin care treatment. The most occurrent reaction 
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mechanism of current skin care agents involve the disruption of tyrosinase. Similarly, 
the same process can be done for the compounds of the husks of C. megalocarpus 
and seeing if any compound can exhibit the same effect as current agents such as 
hydroquinone’s with fewer adverse effects. This would therefore, introduce new ways 
of treating skin conditions using natural products. 
 
1.5. Cancer Activity and Statistics 
Cancer is a disease that has been one of the biggest challenges in the medical indus-
try. Cancer is the occurrence of cells that begin to divide uncontrollably and create a 
cluster of cells that become malignant. Cancer cells have the ability to spread to other 
parts of the body if not treated. According to Cancer Research UK, 17 million new 
cases of cancer were recorded and 9.6 million deaths have been caused by cancer 
since 2018. Cancer Research UK also states that 33% of cancer diagnoses were 
caused by smoking (Cancer Research UK, 2019). However, the four most common 
cancers reported are bowel, prostate, lung and female breast cancer (Cancer Re-
search UK, 2019). Mortality statistics state that lung, stomach, bowel and liver are the 
most common causes of cancer deaths accounting for more than four in ten of all 
cancer deaths (Cancer Research UK, 2019).  
According to the World Health Organisation (WHO), breast cancer is the most com-
mon form of cancer in females. The WHO state that 50% of breast cancer cases and 
58% of mortality happens in less developed countries due to the lack of an efficient 
healthcare system. However, the WHO determine that breast cancer survival rates 
vary from different parts of the world such as >80% in Japan, Sweden and North Amer-
ica, 60% cases in middle income countries and <40% in low income countries (World 
Health Organisation, 2019). Countries that have low income are more vulnerable as 
breast cancer cannot be detected early due to poor facilities and equipment.  
A study by Wong et al (Wong et al., 2017) found that 1.8 million new cases of lung 
cancer were discovered and a total of 1.6 million died of lung cancer in 2012. The 
constituents isolated from Croton species may show significant cytotoxicity and as 
such could provide leads for novel chemotherapies. A study by Chatatikun et al. 
(Chatatikun et al., 2017) reported the cytotoxic effect of ethanolic extract of Croton 
roxburghii (CRE) and Croton sublyratus (CSE) leaves on B16F10 cells. The cells were 
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treated and incubated for 48hrs. The study found that both CRE and CSE showed no 
cytotoxic effects from concentrations ranging from 3.125-100µg/ml for both CRE and 
CSE. The results were significant ***P<.001. Another study by Mulholland et al (Mul-
holland et al., 2010) reported the action of compounds (1) and (4) (Figure 4) against 
PEO1 and PEO1TaxR (taxane resistant) ovarian cancer cell lines. The results showed 
that both compound (1) and (4) were found inactive against PEO1 ovarian cancer 
cells. This goes to show that cytotoxicity effect has been tested for various compounds 
and extracts and shows the gap in the market for validating a compounds ability to 
have a positive effect on cancer.  
 
Aims & Objectives 
The aim of this study was to extract and isolate the phytochemical compounds from                    
C. megalocarpus husks, characterise the isolates, and carry out a tyrosinase inhibitory 
activity assessment and CellTiter MTS assay. Extract phytochemical compounds us-
ing cold solvent on a shaker, isolate compounds using column chromatography and 
thin-layer chromatography (TLC), characterise the isolates using Nuclear Magnetic 
Resonance (NMR), High Resolution Mass Spectrometry (HRMS) and Infrared (IR), 
determining cell cytotoxicity of FM-55 Human Melanoma Cells using CellTiter Assay 
and determine the tyrosinase inhibitory activity using a mushroom tyrosinase inhibition 
assay on a 96 well plate. 
 
2. Experimental 
 
2.1.     Materials and chemicals 
Analytical grade methanol, hexane, dichloromethane, ethyl acetate, ethyl ether, ace-
tonitrile, p-anisaldehyde, chloroform, deuterated chloroform, deuterated methanol, sil-
ica gel 60 (0.015-0.040 mm), pre-coated TLC sheet ALUGRAM SIL G/UV254 0.20 mm 
silica gel 60 with fluorescent indicator UV254, Dulbecco modified eagle medium, feline 
bovine serum (FBS), streptomycin penicillin, PrestoBlue, hydrogen peroxide (30% so-
lution), dimethyl sulfoxide (DMSO), kojic acid, L-tyrosine, mushroom tyrosinase, Nun-
clon 96 well plates, FM-55 human melanoma cells (Public Health England PHE) and 
Etoposide were all purchased from Sigma-Aldrich LTD, The Old Brickyard, NEW 
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ROAD, GILLIGHAM, DORSET, SP8 4XT, UK. The C. megalocarpus plant husks pro-
vided by EFK commercially as C. megalocarpus nuts and kept in the freezer for preser-
vation. Croton vinegar oil was provided by EFK. Analytical instruments used include 
NMR Bruker Avance 400 MHz Coventry, UK, NicoLet IS5 I ID1 transmission IR ma-
chine Paisley, UK, TECAN Infinite M200 microplate reader Theale, UK and HPLC-MS 
(Velos-Pro, Thermo Fisher Scientific; Phenomenex C18 Column: 150 x 3mm Particle 
Size. 
 
2.2. Preparation of husks of C. megalocarpus  
The C. megalocarpus plant husks (650g) were grounded into fine powder using a 
Blendor produced by Waring. Once grounded, the husk powder was stored in a 1000 
mL conical flask. 
 
2.3. Determining of water content of the husks of C. megalocarpus 
The water content of C. megalocarpus was determined to measure the moisture con-
tent. To begin with, ground Croton husks (1.0345g) were weighed and placed in an 
oven that was set at 120oC for 60 minutes. Once dehydrated, the husks were left to 
cool for 10 minutes. Once cooled, the dried husks were reweighed to see the differ-
ence in mass. 
 
2.4. Extraction   
The husks were extracted successively with hexane, dichloromethane and methanol 
using the method outline by Mfotie Njoya et al (Mfotie Njoya et al., 2018). The husks 
were soaked in hexane overnight and followed by filtration. Compounds were ex-
tracted according to their polarity from non-polar to polar. This process was repeated 
twice for each solvent. Once filtered, the crude extract for each solvent was concen-
trated by evaporation using Buchi Rotavapor R-114 and Buchi Waterbath B-480 at 
50oC. The Genevac EZ-2 plus HCI compatible Winchester, UK was used to evaporate 
any remaining solvent for each of the crude extracts of hexane, dichloromethane and 
methanol. The parameters for the evaporation was set at 45oC. After evaporation, the 
following were yielded: hexane (27.90g), dichloromethane (8.30g) and methanol 
(50.80g). The dichloromethane extract was chosen for further analysis. This is 
31 
 
because dichloromethane is a standard solvent used in extracting a wide range of 
organic compounds due to its semi-polar properties and upon examination of the 1H 
NMR, the dichloromethane extract showed the most promising compounds. 
 
2.5. Thin-Layer chromatography 
Thin-Layer chromatography was used to separate the compounds for each crude ex-
tract of hexane, dichloromethane and methanol. The aim of this technique was to de-
termine the range of compounds present in each extract based on their different po-
larities. A pre-coated TLC sheet ALUGRAM SIL G/UV254 was used to spot 10µL of 
each crude extract hexane, dichloromethane and methanol. Different solvent systems 
(mobile phase) were tested to determine best separation of compounds. Some sys-
tems tested were made up of a mixture of two solvents.  
The different solvent systems tested were: hexane (100%), chloroform (100%), di-
chloromethane (100%), dichloromethane with hexane, dichloromethane with ethyl ac-
etate and ethyl acetate (100%). The solvent system that gave best separation of the 
three crude extracts was a combination of dichloromethane and ethyl acetate at a ratio 
of 1:1. A total volume of 20ml of solvent system was poured into the chamber tank and 
left to sit for 20 minutes to saturate the tank. The aluminium backed silica gel plate 
was placed in the chamber tank and allowed for separation until reaching solvent front. 
The plate was viewed under UV light of 365 nm and 254 nm. Visible bands were circled 
using a pencil and plate was then visualised using p-anisaldehyde spray reagent. The 
p-anisaldehyde reagent was sprayed evenly upon the TLC plate, covering the entire 
plate. The plate was then heated using a blow dryer until turning pink. Rf values were 
not measured as this was a visual procedure to have an idea of compounds present 
in the three crude extracts. 
 
2.6. Flash Chromatography – Column 
Column chromatography was used to isolate the compounds of the dichloromethane. 
To begin with, dichloromethane extract was mixed with silica gel and left overnight. 
The purpose of the mixture was to absorb it onto the silica gel to make it easier to load 
onto the column. A teaspoon of sand was placed into the column to form the bottom 
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base followed by silica gel slurry. The silica gel slurry was made by mixing silica gel 
with dichloromethane in a 250 mL beaker. The silica gel slurry was the stationary 
phase of the column. However, the powdered dichloromethane extract was then 
placed inside the column to rest on top of the silica gel. The remainder of the column 
was then filled with the elution solvent that started off with hexane. Once compounds 
had started to separate through the column, fractions were collected in small 100 mL 
beakers. Column chromatography was used in conjunction with TLC and NMR. This 
was to determine which fractions from the column contained compounds and any sim-
ilar compounds which was used for further analysis. After 100 fractions, two solvent 
systems were used for the column in alternating ratio percentages of dichloromethane 
and hexane. A total of 214 fractions were collected for the dichloromethane extract 
roughly collecting 3ml per vial.  
 
2.7. Compound Purification 
Identical fractions identified using NMR and Thin-Layer chromatography were then 
combined. Combined fractions of interest were purified using column chromatography. 
Several combined fractions were analysed as these fractions contained compounds 
of interest. The method required setting up the column and filling with silica. However, 
two different solvent systems were used for each fraction as Thin-Layer chromatog-
raphy analysis showed that the compounds within each fraction had travelled up the 
TLC plate to various different polarity solvents. A combination of dichloromethane and 
ethyl acetate (29:1) were used for fractions 69-74, dichloromethane and hexane (12:8) 
was used for fraction 34-36 and dichloromethane and ethyl acetate (28:2) was used 
for fraction 80-81 from the 214 fractions collected. Once the column was set up, small 
fractions were collected and analysed using NMR Bruker Avance 400 MHz Coventry, 
UK to check for purity and identification of the compound molecular structure. The 
following compounds were isolated and purified: (19), (+)-[1R*,4S*,10R*]-4-hydroxy-
cembra-2E, 7E,11Z-trien-20,10-olide (5), (-)-(1S*,4S*,10R*)-1,4- dihydroxycembra-
2E,7E,11Z-trien-20,10-olide (7), Epoxykaurane (56), Ozic acid (58), Vanillin (59) and 
Sartone A (60) (Table 2) 
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2.8. Infra-red Spectroscopy (IR) 
The isolated compounds were further analysed using IR. IR was used to produce 
peaks of the different functional groups of the compound. A small amount of dichloro-
methane was added to each compound to dissolve. Once done, a few drops of the 
compound were pipetted onto the Sodium chloride disc and allowed for DCM to evap-
orate. Once evaporated, the disc was placed in a NicoLet IS5 I ID1 transmission IR 
machine Paisley, UK and spectra were produced (Appendix E).  
 
2.9. Optical Rotation 
Isolated compounds were further analysed using optical rotation. Optical rotation de-
termined the angle of rotation plane polarised light for chiral compounds. The solvent 
used was dichloromethane and the optical rotation was observed in degrees of rotation 
at a concentration of 1mg/ml.  
 
2.10. Cell Viability 
DAY 1 – The assay methodology was conducted according to a study by Shahbazi-
Gahrouei et al (Shahbazi-Gahrouei et al., 2016). In preparation for cell culture, media 
from a T-25 flask containing FM-55 cells were aspirated and added with 1 ml trypsin. 
The flask was placed in incubator for 5 minutes to allow for detachment of cells from 
flask surface. Once incubated, flask was viewed under microscope to check for 75-
80% confluency. The cell suspension was transferred into a small conical tube and 
added with 10 ml fresh media and centrifuged for 5 minutes at 1000 rpm using Centri-
fuge 5430. Once centrifuged, media was decanted and 5 ml fresh media was added. 
20µl cell suspension was viewed under microscope for cell counting. Cells were 
counted using a haemocytometer to calculate cells needed for seeding. Finally, Nun-
clon 96 well plates were treated with FM-55 cells for 24 hrs. 
DAY 2 – Stock solutions were prepared for each compound being tested. Stock so-
lutions were made up to 20 mg/ml. Serial dilutions were prepared for each sample 
according to Appendix B and B1. The first step involved the addition of 50µl of each 
sample stock solution to wells A1-A12. The positive control in the assay was Etoposide 
(well E11) and the negative control was DMSO (well E12). Once samples were added, 
50µL DMSO was added to each sample to produce a 10mM concentration (x2 fold) 
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and in sequence to row A and E. Then 100µL DMSO was added to each sample to 
make a 5mM concentration. Once done, the samples were diluted with DMEM at 50, 
25, 12.5 and 6µg/ml as shown in Appendix C. Once serial dilutions were prepared, 2µl 
of each dilution was added to 198µl FM-55 cells using epMotion 96 automatic pipette 
dispenser and incubated for 24hrs.  
 
DAY 3 – After 24hrs incubation, cells were treated with 10 µL CellTiter reagent and 
a first reading was taken 2 hours after addition of CellTiter reagent using TECAN Infi-
nite M200 microplate reader Theale, UK at 490 nm.  
 
2.11. Tyrosinase Inhibition Assay  
 
2.11.1. Preparation 
The compounds, C. megalocarpus plant extracts and reagents associated with the 
assay was prepared as follows. Firstly, pure compounds and C. megalocarpus plant 
extracts were prepared respectively at 20mg/ml (crude extract) and 20mM (pure com-
pounds) with dimethyl sulfoxide (DMSO). A phosphate buffer pH 6.5 was prepared by 
mixing 8 ml 0.2M Na2HPO4 (2.84g/100ml) with 17ml 0.2M NaH2PO4 (2.40g/100ml) 
and 75ml H2O to produce a 50mM working buffer. Kojic acid (positive control) was 
prepared with 284.22mg in 100ml deionized water to give 20mM. L-tyrosine was pre-
pared with 1.087mg of substrate with 6ml phosphate buffer and sonicated for 30 
minutes. Mushroom tyrosinase was prepared freshly on day of assay. 1mg of mush-
room tyrosinase was added to 20.53ml phosphate buffer producing 50 units/ml. 
 
 
2.11.2. Tyrosinase inhibition (96 well plate) 
A Nunclon transparent 96 well plate was used for the assay. To begin with, 45µl phos-
phate buffer was added to control and sample wells whilst 145µl was added to blank 
wells. Once added, 5µl of DMSO (negative control), kojic acid (positive control) and 
sample was respectively added to each well according to Appendix A.  Moreover, 50µl 
L-tyrosine was added to all wells using a multichannel pipette. The 96 well plate was 
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then shaken for 5 seconds and left to incubate at room temperature for 2 minutes. 
After 2 minutes, the plate was read using TECAN Infinite M200 microplate reader for 
the background optical density at 475nm. This pre reading was sample + substrate 
excluding tyrosinase enzyme (Tyro-1st). Once reading was recorded, 100µl tyrosinase 
enzyme was added to control and sample wells only. This was done using a multi-
channel pipette to start the reaction at the same time. Once added, the plate was 
shaken for 5 seconds and left to incubate for 15 minutes at room temperature (25oC). 
After 15 minutes, optical density was read at 475nm (Tyro-2nd). The tyrosinase inhibi-
tion activity percentage was calculated using the following formula. Data for both 
CellTiter assay and tyrosinase inhibition was process using GraphPad Prism 8.3.1 
(549). Analytcial tools used include One-way ANOVA and a t test unpaired test. 
 
 
 
3. Results 
 
3.1. Extraction and Isolation 
The C. megalocarpus husks were ground to powder form and were subject to a series 
of solvent based extractions using hexane, dichloromethane and methanol. The fol-
lowing solvent extractions were produced: hexane (27.90g), DCM (8.30g) and metha-
nol (50.80g). The water content that was found in the husks of C. megalocarpus was 
9.17%. The dichloromethane extract was chosen for further analysis due to its ability 
to extract a wide range of organic compounds and promising compounds that was 
determined by 1H NMR, and the compounds isolated and purified using column and 
thin layer chromatography (TLC) techniques were (+)-[1R*,4S*,10R*]-4-hydroxy-
cembra-2E, 7E,11Z-trien-20,10-olide (5), (-)-(1S*,4S*,10R*)-1,4- dihydroxycembra-
2E,7E,11Z-trien-20,10-olide (7), Epoxychiromodine (19), Epoxykaurane (56), Trans 
Ozic acid (58), Vanillin (59) and Sartone A (60) (Table 2). Moreover, pure compounds 
were fully characterised using NMR, HRMS and IR. Processed 1H and 13C spectra can 
be seen in Appendix F. 
 
% inhibition = [(Actrl – Asample) / Actrl] x 100 
Actrl = average optical density of DMSO + substrate with tyrosinase 
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Table 2: HRMS of Compounds Isolated from Dichloromethane Extract of Husks of C megalocarpus 
ID Name Class Accurate 
Mass (g) 
Chemical 
Formula 
Structure 
 
 
 
 
5 
 
 
 
 
 
 (+)-
[1R*,4S*,10R*]-4-
hydroxycembra-
2E, 7E,11Z-trien-
20,10-olide. 
 
 
 
 
 
 
Cembranolide 
(Diterpenoid) 
 
 
 
 
 
357.20 
(LCMS) 
 
 
 
 
 
C20H30O2 
 
 
 
 
 
7 
 
 
 
(-)-(1S*,4S*,10R*)-
1,4- dihydroxy-
cembra-
2E,7E,11Z-trien-
20,10-olide 
 
 
 
 
 
Cembranolide 
(Diterpe-
noids) 
 
 
 
 
 
357.20 
(LCMS) 
 
 
 
 
 
C20H30O3 
 
 
 
 
19 
 
 
 
Epoxychiromodine 
 
 
 
Clerodane 
(Diterpenoid) 
 
 
 
346.1780 
 
 
 
C20H26O5 
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56 
 
 
 
Epoxykaurane 
 
 
 
Kaurane 
(Diterpenoid) 
 
 
 
288.2453 
 
 
 
C20H32O 
 
 
 
 
 
58 
 
 
 
8(17),12, 14-Lab-
datrien-18-ol 
(Ozic Acid) 
 
 
 
Labdane 
(Diterpenoid) 
 
 
 
302.458 
 
 
 
C20H30O2 
 
 
 
 
59 
 
 
 
Vanillin 
 
 
 
Phenolic Al-
dehyde 
 
 
 
152.149 
 
 
 
C8H8O3 
 
 
 
 
  
  
 
 
60 
 
 
Sartone A 
 
 
Cembrane 
(Diterpenoid) 
 
 
304.2402 
 
 
 
 
C20H32O2 
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3.2. Compounds Isolated 
 
Table 3: Correlation Table for NMR Data of Compound 56: Ent-16S,17-epoxykaurane. 
Carbon 
No. 
13C NMR (100 
MHz) in CDCl3 
13C NMR (100 MHz) in 
CDCl3 (Lopes et al., 
1990; Aljancic et al., 
1996)  
1H NMR (400 MHz) 
CDCl3 (J in Hz) 
1α 40.6 CH2 40.4 1.79 m 
1β   0.76 m 
2α 18.8 CH2 18.6 1.58 m 
2β   1.40 m 
3α 42.2 CH2 42.0 1.36 m 
3β   1.11 m 
4 33.4 C 33.2 - 
5 56.4 CH 56.2 0.79 m 
6α 20.4 CH2 20.2 1.54 m 
6β   1.33 m 
7α 41.3 CH2 41.1 1.54 m 
7β   1.54 m 
8 45.6 C 45.4 - 
9 56.1 CH 55.9 1.04 m 
10 39.5 C 39.3 - 
11α 19.5 CH2 19.3 1.71 m 
11β   1.60 m 
12α 29.4 CH2 29.2 1.59 m 
12β   1.55 m 
13 42.9 CH 42.7 1.75 m 
14α 38.8 CH2 38.6 2.02 dd J = 2.0, 11.5 Hz 
14β   1.42 m 
15α 49.1 CH2 48.9 1.66 m 
15β   1.60 m 
16 66.6 C 66.4 - 
17A 50.6 CH2 50.4 2.86 d J = 5.0 Hz 
17B   2.78 d J = 5.0 Hz 
18 21.8 CH3 21.6 0.80 s 
19 33.8 CH3 33.6 0.84 s 
20 18.0 CH3 17.8 1.02  
 
 
Table 4: Correlation Table for NMR Data of Compound 58: Trans Ozic Acid. 
Carbon 
no. 
13C NMR in CDCl3 13C NMR in CDCl3  
(Du et al.,2001)  
1H NMR 
1 38.3 38.1 1.84 m 
   1.21 m 
2 18.6 18.4 1.63 m  
   1.63 m 
3 37.8 37.6 2.37 m  
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   2.09 m 
4 47.6 47.5 - 
5 57.2 57.0 1.86 m 
6 26.8 26.6 1.48 dd J = 4.3, J = 
12.7 Hz 
   1.37 m 
7 37.3 37.1 1.79 m  
   1.66 m 
8 148.0 147.8 - 
9 49.6 49.4 1.99 dd J = 2.8, J = 
12.7 Hz 
10 39.0 38.8 - 
11 23.2 23.0 2.36 m, 2.16 m 
12 133.9 133.6 5.41 t J = 6.4 Hz 
13 133.8 133.5 - 
14 141.8 141.6 6.33 dd J = 10.8, J = 
17.3 Hz 
15 110.2 109.9 5.05 d J = 17.3 Hz  
   4.89 d J = 10.8 Hz 
16 16.6 16.4 117 s 
17 108.4 108.2 4.83 J = 1.0 Hz 
   4.48 J = 1.0 Hz 
18 184.2 185.3 - 
19 14.9 14.7 0.76 s 
20 12.1 11.6 1.75  J = 0.5 Hz 
Carbon 
No. 
13C NMR (100 
MHz) in CDCl3 
13C NMR (100 MHz) in CDCl3  
( Addae-Mensah et al., 1992)  
1H NMR (400 MHz) 
CDCl3 (J in Hz) 
1α 16.4 CH2 16.17 CH2 1.78 m 
1β   1.23 s 
2α 27.9 CH2 27.65 CH2 1.55 m 
2β   2.01 d J = 3.2 Hz 
3 62.4 CH 62.13 CH 2.87 brs W1/2 = 2.8 Hz 
4 66.3 C 66.01 C - 
5 40.6 C 40.39 C - 
6α 35.7 CH2 35.49 CH2 1.67 m 
6β   1.45 d J = 4.0 Hz 
7α 22.4 CH2 22.16 CH2 1.99 d J = 3.0 Hz 
7β   1.70 m 
8 48.8 CH 48.59 CH 3.21 dd J = 3.8, 13.2 Hz 
9 37.2 C 37.04 C - 
10 47.0 CH 46.82 CH 1.80 m 
11α 47.4 CH2 47.20 CH2 2.86* 
11β    
12 194.7 C 194.44 C - 
13 129.2 C 129.0 C - 
14 108.8 CH 108.56 CH 6.73 d J = 1.8 Hz 
15 144.3 CH 144.10 CH 7.40 s 
Table 5: Correlation Table for NMR Data of Compound 19: Epoxychiromodine 
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16 147.3 CH 147.04 CH 8.02 brs W1/2 = 3.0 Hz 
17 175.1 C 174.86 C - 
18 19.8 CH3 19.83 CH3 1.15 s 
19 16.9 CH3 16.64 CH3 1.08 s 
20 20.0 CH3 19.61 CH3 0.88 s 
17-OMe 51.4 CH3 51.13 CH3 3.59 s 
Table 6: Correlation Table for NMR Data of Compound 60: Sartone A 
Carbon 
no. 
13C NMR in CDCl3 13C NMR in CDCl3  
 (Iwagawa et al., 1996)   
1H NMR 
1 46.5 46.3 1.52 m 
2 130.2 130.0  5.28 dd J = 8.6, 16.1 Hz 
3 137.6 137.4 5.63 d J = 16.1 Hz 
4 72.6 72.4 - 
    
5 42.6 42.4 2.02 m  
   1.56 m 
6 22.6 22.3 2.58 m  
   2.14 m 
7 133.7 133.4 5.38 m 
8 129.0 128.8 - 
9 57.3 57.1 3.03 d  J = 14.0 Hz 
   2.86 d  J = 14.0 Hz 
10 200.3 199.9 -  
11 122.3 122.1 6.23 s 
12 158.0 157.8 -  
13 38.9 38.6 - 
14 27.8 27.6 6.23 s 
15 33.0 32.8 1.50 m 
16 19.4 19.4 0.81 d  J = 7.0 Hz 
17 20.8 20.8 0.83 d J = 7.0 Hz  
18 28.6 28.4 1.40 s 
19 16.8 16.5 1.65 s 
20 18.0 17.7 2.09 s 
Table 7: Correlation Table for NMR Data of Compound 5: (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 
7E,11Z-trien-20,10-olide 
 
Carbon No. 
13C NMR (125 MHz)  
in CDCl3 
13C NMR (100 MHz) in 
CDCl3 (Mulholland et al., 
2010)  
1H NMR (400 MHz) 
CDCl3 (J in Hz) 
1 48.4 CH 48.4 CH 1.57 m 
2 131.4 CH 131.4 CH 5.43 dd J = 8.7, 15.7 
3 138.0 CH 138.0 CH 5.61 d J = 15.7 Hz 
4 72.5 C 72.5 C - 
5α 43.7 CH2 43.7 CH2 1.93 m 
5β   1.51 m 
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Carbon 
No. 
13C NMR (100 
MHz) in CDCl3 
13C NMR (100 MHz)  
in CDCl3 (Langat et al., 
2011) 
1H NMR (400 MHz) 
CDCl3 (J in Hz) 
1 78.9 C 77.9 C - 
2 132.7 CH 131.9 CH 5.65 br s W1/2 = 1.8 Hz 
3 136.8 CH 135.8 CH 5.64 br s W1/2 = 1.8 Hz 
4 74.9 C 72.9 C - 
5α 43.3 CH2 42.4 CH2 1.71 m 
5β   1.73 m 
6α 24.1 CH2 23.2 CH2 2.16 m 
6β   2.08 m 
7 133.2 CH 131.8 CH 5.15 m 
8 129.1 C 128.1 C - 
9α 41.9 CH2 42.4 CH2 2.54 m 
9β   2.58 m 
10 82.8 CH 80.6 CH 5.26 m 
11 150.3 CH 148.5 CH 7.20 br s W1/2 = 1.8Hz 
12 136.0 C 135.3 C - 
13α 21.5 CH2 21.3 CH2 2.30 m 
6α 25.6 CH2 25.6 CH2 2.33 m 
6β   1.59 m 
7 131.1 CH 131.1 CH 5.37 t J = 7.5 Hz 
8 129.4 C 129.4 C - 
9α 44.7 CH2 44.7 CH2 
2.80 dd J = 2.6, 12.7 
Hz 
9β   
2.07 dd J = 2.6, 12.7 
Hz 
10 80.3 CH 80.3 CH 
5.04 br s W1/2 = 19.6 
Hz 
11 149.6 CH 149.6 CH 6.97 d J = 3.4, 1.7 Hz 
    
12 133.6 C 133.6 C - 
13α 22.7 CH2 22.7 CH2 2.20 m 
13β   2.20 m 
14α 28.1 CH2 28.2 CH2 1.94 m 
14β   1.49 m 
15 33.9 CH 33.8 CH 1.60 m 
16 20.4 CH3 20.4 CH3 0.84 d J = 6.5 Hz 
17 19.6 CH3 19.7 CH3 0.89 d J = 6.5 Hz 
18 28.2 CH3 28.1 CH3 1.37 s 
19 16.5 CH3 16.5 CH3 1.67 s  
20 174.2 C 174.2 C - 
Table 8: Correlation Table for NMR Data of Compound 7: (-)-(1S*,4S*,10R*)-1,4- dihydroxy-
cembra-2E,7E,11Z-trien-20,10-olide 
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13β   2.32 m 
14α 34.5 CH2 33.7 CH2 2.01 m 
14β   1.92 m 
15 38.9 CH 38.9 CH 1.74 m 
16 17.9 CH3 17.1 CH3 0.96 d J = 6.8 Hz 
17 17.6 CH3 17.5 CH3 0.92 d J = 6.8 Hz 
18 29.7 CH3 28.8 CH3 1.29 s 
19 18.9 CH3 17.9 CH3 1.59 s 
20 176.6 C 174.5 C - 
 
 
 
 
 
 
Table 9: Correlation Table for NMR Data of Compound 59: Vanillin 
 
Carbon 
No. 
13C NMR (100 
MHz) in CDCl3 
13C NMR (100 MHz) 
in CDCl3 (Bai et al. 
2018)  
1H NMR (400 
MHz) 
CDCl3 (J in Hz) 
1H NMR (400 MHz) 
CDCl3 (J in Hz) (Mukonyi 
and Ndiege) 
1 133.3 C 135.7 - - 
2 108.9 CH 111.3 7.41 d J = 2.0 Hz 7.41 m 
3 149.6 C 152.0 - - 
4 147.5 C 149.9 - - 
5 114.5 CH 122.9 7.04 d J = 8.5 Hz 7.03 d J = 8.6 Hz 
6 127.7 CH 124.7 
7.37 d J = 2.0, 8.5 
Hz 
7.41 m 
7 191.1 CH 190.1 9.82 s 9.81 s 
3-OCH3 56.3 56.4 3.97, s 3.96, s 
4-OH - - 6.21, s 6.21, s 
Table 10: Correlation Table for IR and LC-MS Data of The Five Compounds Isolated 
 Compound Absorption Band Frequency cm-1 Molecular Ion Peak [M]+ 
m/z 
3,4-Epoxide-15,16-epoxy-
3,13(16),14-clerodatriene 
(19) 
3452 and 2848 C-H stretch 
1713 C=O stretch 
 
346.1 
Ent-16S,17-epoxykau-
rane (56) 
2848 C-H stretch 
1461 C-H bend alkane group 
1110 C-O stretch epoxide 
 
288.2 
8(17),12, 14-Labdatrien-
18-ol trans ozic acid (58) 
2930, 2867 and 1693 C-H stretch 
for CH2 and CH3 
1642 and 891 stretch C=C 
 
302.4 
Vanillin (59) 3417 OH  
1714 C=O stretch 
1714 and 1264 C=O and R-O-R 
 
152.14 
Sartone A (60) 3054 dicative OH group 
1712 and 1614 β unsaturated C=O 
moiety 
 
304.2 
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3.3. Mushroom Tyrosinase Inhibition Assay 
The C. megalocarpus compounds isolated from the husks were subject to bioassays 
including mushroom tyrosinase inhibition assay (Figure 9). Several extracts of C. 
megalocarpus were tested to see any variance of properties that each extract may 
have. The husks, seedcake and fruit cake were subject to different solvent extracts of 
hexane, dichloromethane and methanol. For the assay, all isolated compounds were 
prepared at 20mM whereas extracts were made at 20mg/ml. The Croton vinegar oil is 
an organic fertiliser and was tested in the same manner as the other samples. After 
the assay was conducted, several compounds and extracts that showed interesting 
inhibition were repeated for validation (Figure 10). 
 
 
Figure 9: Tyrosinase inhibition of compounds/extracts of husks of C. megalocarpus. Hexane extract 
of husks (S1), hexane extract of husks with mould (S2), hexane extract of fruit cake (S3), hexane  extract 
of seeds (S4), hexane extract oil (S5), methylene chloride extract of husks (S6), methylene chloride ex-
tract of husks with mould (S7), methylene chloride extract of fruit cake (S8), methylene chloride extract 
of seeds (S9), methylene chloride extract of Croton  vinegar oil (S10), methanol extract of husks (S11), 
methanol extract of fruit cake (S12), methanol extract of seeds (S13), trans ozic acid (S14), sartone A 
(S15), epoxykaurane (S16), epoxychiromodine (S17), ethyl acetate extract of Croton vinegar oil (S18), 
pure Croton vinegar oil (S19) and magnoflorine (S20). 
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3.4. FM-55 Human Melanoma Cells (Cytotoxicity Assay) 
The C. megalocarpus compounds isolated from the husk were subject against FM-55 
human melanoma cells. The same compounds and extracts were tested in the same 
manner as the tyrosinase assay. In this assay, the results provide a varied analysis 
for the effect of compounds and extracts on FM-55 human melanoma cells. Isolated 
compounds were made at 20mM and extracts were made at 20mg/ml. The com-
pounds and extracts were done in triplicate repeats. Absorbance data were converted 
to cell viability %.  
 
 
 
 
 
 
Figure 11: Cell Viability of compounds and extracts at 50µg/ml 
Figure 10: Tyrosinase inhibition of the five compounds/extracts of interest. epoxychiromodine (S17), mag-
noflorine (S20), methanol extract of husks (S11), methylene chloride extract of husks with mould (S7) and 
ethyl acetate extract of croton vinegar oil (S18) n=3. Compounds/extract (S7) (p<0.0052), (S17) (p<0.0052), 
(S18) (p<0.0012) and (S20) (p<0.0393) were significant p<0.05 compared to kojic acid. Methanol extract of 
husks (S11) showed to not be significant with p<0.0542. 
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Figure 11A: Cell Viability of compounds and extracts at 25µg/ml 
Figure 11B: Cell Viability of compounds and extracts at 12.5µg/ml 
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4. Discussion 
 
4.1. Compounds Isolated  
 
4.1.1.    Ent-16S,17- epoxykaurane (56) 
Compound (56) was isolated from the dichloromethane extract of husks of C. megalo-
carpus. Compound (56) was identified by analysis of the 1H, 13C and 2-D NMR spec-
tra as well as the mass spectrum and the IR spectrum as the known ent-16S,17- 
epoxykaurane, previously isolated from Aristolochia triangularis (Lopes et al., 1990) 
and Achillea clypeolata (Aljancic et al., 1996). The LC-MS data for compound (56) 
gave a molecular ion peak [M]+ at 288.2453 m/z which indicated a molecular formula 
Figures 11, 11A, 11B, 11C: Data accumulated from mean and standard deviation of each extract, n=3 from 
GraphPad Prism 8. Etoposide used as positive control and DMSO used as negative control. Hexane extract of husks 
(S1), hexane extract of husks mould (S2), hexane extract of fruit cake (S3), hexane extract of seeds (S4), hexane ex-
tract oil (S5), methylene chloride extract of husks (S6), methylene chloride extract of husks with mould (S7), meth-
ylene chloride extract of fruit cake (S8), methylene chloride extract of seeds (S9), methylene chloride extract of Cro-
ton  vinegar oil (S10), methanol extract of husks (S11), methanol extract of fruit cake (S12), methanol extract of 
seeds (S13), trans-ozic acid (S14), sartone A (S15), epoxykaurane (S16), epoxychiromodine (S17), ethyl acetate ex-
tract of Croton vinegar oil (S18) and magnoflorine (S19). 
Figure 11C: Cell Viability of compounds and extracts at 6µg/ml 
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of C20H32O. IR of compound (56) showed an absorption band at 2848 cm-1 for C-H 
stretch, a 1461 cm-1 for C-H bend alkane group, a 1110 cm-1 C-O stretch for epoxide. 
The 1H and 13C NMR spectroscopic data for compound (56) are shown in Table 3. 
The 13C NMR chemical shifts of compound (56) were identical to those reported in the 
literature for ent-16S,17- epoxykaurane. The optical rotation value for compound (56) 
was + 0.07o whilst the value obtained from literature is -55o (Aljančić et al., 1996). In 
consideration of NMR, HRMS and IR, compound (56) was confirmed to be the known 
ent-16S,17- epoxykaurane. 
 
4.1.2. 8(17),12, 14-Labdatrien-18-ol (ozic acid) (58) 
Compound (58) was isolated from the dichloromethane extract of husks of C. mega-
locarpus. Compound (58) was identified by analysis of the 1H, 13C and 2-D NMR 
spectra as well as the mass spectrum and the IR spectrum as the known 8(17),12, 14-
Labdatrien-18-ol, previously isolated from Cunninghamia lanceolate (Du et al., 2001) 
and Daniellia species (Bevan et al., 1968). The LC-MS data for compound (58) gave 
a molecular ion peak [M]+ at 302.458 m/z which indicated a molecular formula of 
C20H30O2. IR of compound (58) showed an absorption band at 2930, 2867 and 1693 
cm-1 for C-H stretch for CH2 and CH3 and a C=C double bond at 1642 and 891 cm-1. 
The 1H and 13C NMR spectroscopic data for compound (58) are shown in Table 4. 
The 13C NMR chemical shifts of compound (58) were identical to those reported in the 
literature for trans ozic acid. The optical rotation value for compound (58) was + 0.090 
whilst the value quoted in the literature is -47o (Du et al., 2001). In consideration of 
NMR, HRMS and IR, compound (58) was verified to be trans ozic acid. 
 
4.1.3. 3,4-Epoxide-15,16-epoxy-3,13(16),14-clerodatriene (19) 
Compound (19) was isolated from the dichloromethane extract of the husks of C. meg-
alocarpus. Compound (19) was identified by analysis of the 1H, 13C and 2-D NMR 
spectra as well as the mass spectrum and the IR spectrum as the known epoxychiro-
modine, previously isolated from C. megalocarpus (Addae-Mensah et al., 1992). LC-
MS analysis gave a molecular ion peak [M]+ reading of 346.1780 m/z which indicated 
a molecular formula of C20H26O5. IR of compound (19) showed absorption bands at 
3452 and 2848 cm-1 for C-H stretch, 1713 cm-1 for C=O stretch. The 1H and 13C NMR 
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spectroscopic data for compound (19) are shown in Table 5. The 13C NMR chemical 
shifts of compound (19) are similar to those reported in the literature for epoxychiro-
modine. The optical rotation value obtained for compound (19) was + 0.01o whilst the 
value obtained in the literature was -31o (Addae-Mensah et al., 1992). With respect to 
the HRMS data, 1H and 13C NMR, it can be confirmed that compound (19) is the known 
epoxychiromodine. 
 
4.1.4. Sartone A (60) 
Compound (60) was isolated from the dichloromethane extract of husks of C. mega-
locarpus. Compound (60) was identified by analysis of the 1H, 13C and 2-D NMR 
spectra as well as the mass spectrum and the IR spectrum as the known sartone A, 
previously isolated from soft coral Sarcophyton (Iwagawa, T et al., 1996). LC-MS data 
for compound (60) revealed the molecular ion peak [M]+ of 304.2402 m/z which 
indicated a molecular formula of C20H32O2. IR of compound (60) showed absorption 
bands at 3054 cm-1 for indicative hydroxy group and a 1712 C=O and 1614 cm-1 double 
bond that forms a α, β unsaturated keto carbonyl group (van Zandvoort et al., 2015). 
The 1H and 13C NMR spectroscopic data for compound (60) are shown in Table 6. 
The 13C NMR chemical shifts of compound (60) were identical to those reported in the 
literature for sartone A. The specific rotation value for compound (60) was + 0.0o whilst 
the value obtained from the literature is +134.6o (Iwagawa, T et al., 1996). In consid-
eration of NMR, HRMS and IR, compound (60) was confirmed to be the known sartone 
A.  
4.1.5. (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 7E,11Z-trien-20,10-
olide (5) 
Compound (5) was isolated from the dichloromethane extract of husks of C. megalo-
carpus. Compound (5) was identified by analysis of the 1H, 13C and 2-D NMR spectra 
as well as the mass spectrum and the IR spectrum as (+)-[1R*,4S*,10R*]-4-hydroxy-
cembra-2E, 7E,11Z-trien-20,10-olide, previously isolated from stem bark of Croton 
gratissimus (Mulholland et al., 2010). NMR analysis of compound (5) indicated a mo-
lecular formula of C20H30O3 with a molecular mass of 357.20 m/z. Literature confirmed 
the IR absorption band of compound (5) showed presence of carbonyl stretch at 1738 
cm-1 which indicates a α, β unsaturated 5 membered lactone and O-H stretch at 3411 
cm-1 (Mulholland et al., 2010). The 1H and 13C NMR spectroscopic data for compound 
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(5) are shown in Table 7. The 13C NMR chemical shifts of compound (5) were identical 
to those reported in the literature for (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 7E,11Z-
trien-20,10-olide. Therefore, compound (5) is confirmed to be (+)-[1R*,4S*,10R*]-4-
hydroxycembra-2E, 7E,11Z-trien-20,10-olide. 
 
4.1.6. (-)-(1S*,4S*,10R*)-1,4- dihydroxycembra-2E,7E,11Z-trien-
20,10-olide (7) 
Compound (7) was isolated from the dichloromethane extract of husks of C. megalo-
carpus. Compound (7) was identified by analysis of the 1H, 13C and 2-D NMR spectra 
as well as the mass spectrum and the IR spectrum as (-)-(1S*,4S*,10R*)-1,4- dihy-
droxycembra-2E,7E,11Z-trien-20,10-olide, previously isolated from leaves of Croton 
gratissimus (Langat et al., 2011). NMR analysis of compound (7) indicated a molecular 
formula of C20H30O4 with a molecular mass of 357.20 m/z. Literature confirms IR ab-
sorption bands of compound (7) was 3421 cm-1 for hydroxy group and 1757 cm-1 for 
α, β unsaturated γ lactone (Langat et al., 2011). The α, β unsaturated γ lactone was 
determined as the C=O stretching is shifted between 15-25 cm-1 lower frequency in 
unsaturated environment than an unconjugated C=O (Pavia et al., 2009) The 1H and 
13C NMR spectroscopic data for compound (7) are shown in Table 8. The 13C NMR 
chemical shifts of compound (7) were identical to those reported in the literature as (-
)-(1S*,4S*,10R*)-1,4- dihydroxycembra-2E,7E,11Z-trien-20,10-olide. Therefore, com-
pound (7) is confirmed to be (-)-(1S*,4S*,10R*)-1,4- dihydroxycembra-2E,7E,11Z-
trien-20,10-olide. 
4.1.7. Vanillin (59) 
Compound (59) was isolated from the dichloromethane extract of husks of C. mega-
locarpus. Compound (59) was identified by analysis of the 1H, 13C and 2-D NMR 
spectra as well as the mass spectrum and the IR spectrum as the known vanillin, which 
is a common isolate from a range of plant species (Bai De et al., 2018). LC-MS data 
showed the molecular ion peak [M]+ of 152.149 m/z which confirmed the molecular 
formula of C8H8O3. IR of compound (59) showed absorption bands at 3417 cm-1 broad 
peak for hydroxyl group OH, a 1714 cm-1 for carbonyl group stretch, a 1714 and 1264 
cm-1 for carbonyl groups and ether groups. The 1H and 13C NMR spectroscopic data 
for compound (59) are shown in Table 9. The 13C NMR chemical shifts of compound 
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(59) were identical to those reported in the literature for vanillin. Therefore, both IR 
and NMR analysis confirm that compound (59) is vanillin.  
 
4.1.8. Mushroom Tyrosinase Inhibition Assay 
Tyrosinase inhibition of isolated compounds and extracts of husks of C. megalocarpus 
showed varied results. The tyrosinase assay is a technique used to determine the 
inhibition rate of tyrosinase. Tyrosinase is an important enzyme in the role of melanin 
production in the skin. Tyrosine reacts with tyrosinase to produce melanin. In this as-
say, the compounds being tested are placed in a well of a 96 well plate along with 
tyrosinase and tyrosine in their respective quantities (see section 2.11.2). The reaction 
of tyrosine and tyrosinase turns a reddish/brown colour when reacted over time. This 
colourisation indicates the production of dopaquinone. The 96 well plate is then placed 
in the micro plate reader before addition of tyrosinase and post addition of tyrosinase. 
The difference is calculated and the inhibitory rate is determined.  
Tyrosinase inhibition assay was chosen in this project as tyrosinase is an important 
enzyme that is targeted by current skin lightening agents such as hydroquinone and 
mercury. Applying the same protocol for the compounds/extracts of husks, seed and 
fruit cake of C. megalocarpus, it can be determined whether any of the compounds or 
extracts may exhibit the same mechanism as hydroquinone. The successful com-
pound would then be tested for its cytotoxic effect on cells to determine its safety. The 
combination of tyrosinase inhibition and cytotoxicity enables the characterisation of 
successful compounds with further analysis and an alternative to the current skin light-
ening agents that are being used. Kojic acid was used as the positive control and 
DMSO as the negative control.  
Kojic acid has the ability to inhibit tyrosinase and is a known positive control against 
tyrosinase. Kojic acid is also used for skin care as it is a most common ingredient in 
creams and lotions in the cosmetic industry. Kojic acid was used in the study by 
Chatatikun et al (Chatatikun et al., 2017). Kojic acid was shown to inhibit tyrosinase at 
150% at 250µg/ml. The results also showed that both Croton roxburghii (CRE) and 
Croton sublyratus (CSE) lowered tyrosinase activity at lower concentrations of 6.25-
50µg/ml as opposed to kojic acid at 250µmg/ml. The use of current skin lightening 
such as hydroquinone’s, mercury and corticosteroids while shown to be effective, have 
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also been shown to have adverse effects on people such as acne vulgaris, hypertri-
chosis, perioral dermatitis, dischromias and ochronosis (Yusuf et al., 2019).  
This has led African nations such as Sudan, Ghana and South Africa to ban the use 
of skin lightening products that contain these ingredients. For this assay, the template 
was carried out according to Appendix A. Using a Nunclon transparent 96 well plate, 
145µL of phosphate buffer was added to blank wells and 50µL was added to control 
and sample wells. 5µL of kojic acid, DMSO and compound/extract was added to their 
respective wells. 50µL of tyrosine substrate was added to all wells and the 96 well 
plate was shaken for 5 seconds and left to incubate at room temperature (23oC) for 2 
minutes. The plate was placed in the TECAN Infinite M200 microplate reader (Theale, 
UK) and a pre reading was noted. 100µL of freshly made mushroom tyrosinase was 
added to control and sample wells.  
The plate was incubated at room temperature for 15 minutes and a second reading 
was taken. The results for the tyrosinase inhibition assay are shown in Figure 9. Com-
pounds/extracts that showed a high or promising inhibition rate were repeated to vali-
date the inhibition activity. Repeats were done for epoxychiromodine (S17), magnoflor-
ine (S20), methanol extract of husks (S11), methylene chloride extract of husks with 
mould (S7) and ethyl acetate extract of croton vinegar oil (S18) (n=3). Significance of 
the results was not analysed as only 5 compounds/extracts of interest were repeated. 
Hexane extract of husks (S1), hexane extract of husks with mould, (S2), hexane ex-
tract of fruit cake (S3) and Croton vinegar oil (S19) showed similar inhibition effects at 
14.5, 11.3, 14.4 and 15.2%. Hexane extract of the seeds (S4), hexane extract oil (S5), 
methylene chloride extract of husks (S6), methylene chloride extract of husks with 
mould (S7), methylene chloride extract of fruit cake (S8), methylene chloride extract 
of seeds (S9), methanol extract of husks (S11), methanol extract of fruit cake (S12), 
methanol extract of seeds (S13), sartone A (S15) and ent-16S,17-epoxykaurane (S16) 
showed significantly low inhibition activity against tyrosinase at 1.9, 4.4, 6.6, 5.2, 8.3, 
5.6, 3.0, 9.6, 7.5, 3.3 and 7.0% in comparison to kojic acid at 92.44%.  
The methylene chloride extract of Croton vinegar oil (S10) and trans ozic acid (S14) 
showed a slightly higher inhibition at 17.5 and 19.0%. Epoxychiromodine (S17) and 
magnoflorine (S20) inhibited nearly a quarter of the enzyme activity at 26.8 and 24.0%. 
The ethyl acetate extract of Croton vinegar oil (S18) showed an inhibition of 59.3% 
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therefore inhibiting over 50% of the enzyme’s activity. According to a study by 
Chatatikun et al (Chatatikun et al., 2017), the leaves of Croton roxburghii and Croton 
sublyratus produced inhibition rates of 117.2% at 50µg/ml and 159.3% inhibition at 
100µg/ml for both Croton roxburghii and Croton sublyratus (Chatatikun et al., 2017) 
with comparison to kojic acid at 150%.  
The compounds/extracts for this experiment were made at 20µg/ml (extracts) and 
20mM (pure compounds) respectively as opposed to the parameters used by 
Chatatikun et al (Chatatikun et al., 2017) that was using concentration from 3.125-
50µg/ml for CRE and 3.125-200µg/ml for CSE. The CRE and CSE were ethanolic 
extracts of the leaves whilst methanol, methylene chloride and hexane were used for 
husks, seed and fruit cake of C. megalocarpus. As the study by Chatatikun et al 
(Chatatikun et al., 2017) was also based on Croton, this shows the applications of 
diterpenoids from Croton to be used for potential natural product cosmetic treatments 
as the results obtained showed promising results. Graphical representation for the ty-
rosinase inhibition can be seen in Figure 9. Moreover, graphical data was also pro-
duced for five compounds/extract of interest that were repeated due to their ability to 
inhibit tyrosinase (Figure 10). T test analysis showed that compounds/extract (S7) 
(p<0.0052), (S17) (p<0.0052), (S18) (p<0.0012) and (S20) (p<0.0393) were significant 
p<0.05 compared to kojic acid. Compound/extract S11 showed to not be significant 
with p<0.0542. 
4.1.9. FM-55 Human Melanoma Cells (Cytotoxicity Assay) 
Cytotoxicity of compounds/extracts of C. megalocarpus showed some varied results. 
The cytotoxicity assay that was conducted was an MTS assay of CellTiter 96 Aqueous 
One Solution Cell Proliferation Assay. CellTiter involves the quantification of viable 
cells after addition of the desired test substance and seeing a decrease in the number 
of cells that would indicate the test substance ability to kill cells. The compound used 
in this assay is [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sul-
fophenyl)-2H-tetrazolium (Barltrop, J.A. et al., 1991). The assay is based on the abun-
dancy of formazan that is produced when CellTiter is reduced (Figure 12) by viable 
cells and then measured by the absorbance (Barltrop, J.A. et al., 1991).  
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The cells are treated with varied concentrations of the test substance and a positive 
and negative control are assigned. The positive and negative control are kept at a 
constant concentration. After 24 hours incubation, the cells are treated with CellTiter 
reagent and incubated for a further 2hrs. The plate is then read in the microplate reader 
and absorbance is noted. CellTiter luminescent cell viability assay was chosen as it is 
a fast and easy assay to conduct. The assay only requires up to 30hrs of experimental 
time. The mechanism of CellTiter assay involves the ability for viable active cells to 
convert MTS into formazan (Riss et al., 2013). Formazan is a purple coloured chemical 
that is detectable at 570nm on the microplate reader (Riss et al., 2013). 
Dead cells no longer are able to convert MTS to formazan and therefore colourisation 
serves as an indicator for viable cells (Riss et al., 2013). On the other hand, some 
factors that were considered for the outcome of the assay such as the ability for the 
compounds/extracts to reduce the MTS CellTiter reagent rather than the viable cells. 
This would result in higher cell viability and therefore give a false reading. Natural 
products are isolated in small quantities and is another reason for not being able to 
have enough to make up to the desired stock concentration.  
Administrating low stock concentrations of the compounds/extracts may not give it 
enough strength to kill the cells. The FM-55 cells used in this assay were found to be 
sensitive when subjected to centrifugation. Centrifugation revealed to have disturbed 
the cells in the form of large clumps. Therefore, centrifugation was avoided to allow 
proper and equal distribution of cells into the 96 well plates. In this MTT-type assay, 3 
separate 96 well plates were prepared and seeded with approximately 10,000 FM-55 
cells in each well. On the stock solution 96 well plate, 50µL of each compound/extract 
was added to their designated wells. Etoposide was used as the positive control and 
DMSO (1%) as the negative control. A total of 100µL DMSO was added to each com-
pound/extract and the following concentrations were produced by addition of DMEM: 
50, 25, 12.5 and 6µg/ml. Each compound/extract was added to the FM-55 cells and 
incubated for 24hrs. After 24hrs, CellTiter reagent was added to the cells and absorb-
ance was measured after 2hrs. Cell viability was calculated using the following for-
mula. 
[(Sample absorbance average / Negative Control absorbance average)] x 100 
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Cytotoxicity analysis is important as a range of different cells can be tested on com-
pounds of interest. The cytotoxic potential of a compound can be tested against 
healthy skin cells and cancerous melanoma cells. This would provide the behavioural 
characteristics of the compound of interest and enable and encourage more use of 
natural products in treatment for cancer. A study by Chatatikun et al (Chatatikun et al., 
2017) reported the results of Croton roxburghii (CRE) and Croton sublyratus (CSE) 
leaves on B16F10 cells. Compounds (1) and (4) (Figure 4) were tested against PEO1 
and PEO1TaxR (taxane resistant) ovarian cancer cell lines. The results showed that 
both compound (1) and (4) were found inactive against PEO1 ovarian cancer cells.  
Figure 12: MTS CellTiter reduction of [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium into formazan. The CellTiter reagent is reduced by active viable cells 
and the quantity of formazan is measured by the absorbance. 
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The CellTiter assay results were found to be significant P<0.05. Figure 11 represents 
the isolated compounds and extracts at a concentration of 50µg/ml. The results at 
50µg/ml revealed that compounds/extracts hexane extract of husks (S1), hexane ex-
tract of seeds (S4), methanol extract of husks (S11), methanol extract of fruit cake 
(S12), methanol extract of seeds (S13) and trans ozic acid (S14) showed cell viability 
above 100% with a CI ranging from 65.04-157.5%. This indicated that these com-
pounds and extracts induced cell growth rather than killing the FM-55 cells. The meth-
ylene chloride extract of husks (S6) showed to kill the FM-55 cancer cells with a cell 
viability of 45.62% with a CI of 21.78-69.47% compared to etoposide that produced a 
cell viability of 68.13% with an CI at 5.853-130.4%.  
Therefore, the methylene chloride extract of husks (S6) showed to kill the cells more 
effectively than etoposide which is an approved drug used for treatment of cancer. 
Compounds/extracts hexane extract of husks with mould (S2), hexane extract of fruit 
cake (S3), hexane extract oil (S5), methylene chloride extract of husks with mould 
(S7), methylene chloride extract of seeds (S9), methylene chloride extract of Croton 
vinegar oil (S10), sartone A (S15), epoxykaurane (S16), epoxychiromodine (S17), 
ethyl acetate extract of Croton vinegar oil (S18) and Magnoflorine (S19) showed to kill 
a small amount of FM-55 cell with no major effect and produced CI from 30.43-163.4%.  
At 25µg/ml (Figure 11A), the results showed to be varied. Hexane extract of husks 
with mould (S2) was shown to have increased in cell viability above 100% with a 95% 
CI from 82.89-152.9% and indicates that at a lower concentration, it may have aided 
in cell growth rather killing the cells. Hexane extract of fruit cake (S3), hexane extract 
of seeds (S4) and hexane extract oil (S5) showed to have killed a small number of FM-
55 cells compared to concentrations at 50µg/ml with a CI ranging from 49.04-123.3%. 
Moreover, methylene chloride extract of husks (S6) showed to increase in cell viability 
thus not being able to kill the FM-55 cells compared to the concentration at 50µg/ml.  
The remaining compounds/extracts hexane extract of husks (S1), methylene chloride 
extract of husks with mould (S7), methylene chloride extract of fruit cake (S8), meth-
ylene chloride extract of seeds (S9), methylene chloride extract of Croton vinegar oil 
(S10), methanol extract of husks (S11), methanol extract of fruit cake (S12), methanol 
extract of seeds (S13), trans ozic acid (S14), sartone A (S15)  epoxykaurane (S16), 
epoxychiromodine (S17), ethyl acetate extract of Croton vinegar oil (S18) and 
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magnoflorine (S19) did not show much difference in cell viability compared to 50µg/ml 
with a CI at 35.25-150%. At 12.5µg/ml (Figure 11B), the results appear to be virtually 
identical to the concentration at 25µg/ml with a small amount of variance.  
The methylene chloride extract of the husks (S6) had showed to be higher in cell via-
bility than 50µg/ml. At this stage of the experiment, it is indicated that the methylene 
chloride extract of husks (S6) is more effective at higher concentrations on FM-55 
human melanoma cells and not so effective at lower concentrations. The concentra-
tion at 6µg/ml (Figure 11C) was shown to be virtually identical to the concentration at 
12.5µg/ml with small variance. T test analysis can be seen in Appendix D. Overall, 
the results showed to be varied but most effective at 50µg/ml. The effectiveness and 
ability of the compounds/extracts to kill FM-55 cells is reduced as the concentration is 
lowered. The methylene chloride extract of the husks (S6) showed to kill the FM-55 
cells with a cell viability of 45%. 
In comparison to the isolated compounds of the methylene chloride extract, the extract 
is shown to have more positive effect on the FM-55 melanoma cells rather than the 
individual compounds themselves. This analysis indicates synergism as the com-
pounds increase their activity when used together. On the other hand, the tyrosinase 
assay data (Figure 9) shows that trans ozic acid (S14), epoxykaurane (S16) and 
epoxychiromodine (S17) inhibit tyrosinase with rates of 19.04, 7.03 and 26.82% in 
comparison of methylene chloride extract of husks (S6) 6.61% and therefore is better 
individually rather than as an extract. However, another possible explanation for the 
methylene chloride extract of husks (S6) cytotoxic effect is the presence of a com-
pound that was not isolated.  
The compound present in the methylene chloride extract may be killing the FM-55 cells 
rather than the isolated compounds. The ethyl acetate extract of Croton vinegar oil 
(S18) showed a tyrosinase inhibition of 59.30% and a weak toxicity with a cell viability 
of 91.87% and is a suitable subject for skin lightening and skin care. The tyrosinase 
inhibition of the ethyl acetate extract of Croton vinegar oil (S18) may also be synergis-
tic as there may be compounds that are inhibiting tyrosinase together or an individual 
compound.  
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The analytical techniques used in this project were suitable as they are standard tech-
niques used in the isolation and characterisation of natural products. Column chroma-
tography (CC) was used to isolate and purify compounds subject to an array of solvent 
systems. CC was effective in producing a large production of samples which also con-
tributed to greater quantity of compound. This technique was used in conjunction with 
TLC. TLC is a visual technique that indicates the presence of compounds within the 
extract. 
TLC helped determine the quantity of compounds that separate after the addition of 
p-anisaldehyde. TLC is fast and reliable. Once determining the vial of interest, NMR 
was used to see the purity of the compound. NMR was also used to identify the number 
of hydrogens and carbons, confirming it to be a diterpenoid as diterpenoids were of 
interest in this project. Compounds that showed to be impure were subject to column 
again to purify the compound. NMR was the backbone in providing the characteristics 
of the compounds. LC-MS was a useful analytical technique and used as a confirma-
tory for the compounds by identifying the mass. The mass identified was then con-
firmed using an established chemical finder. IR was used to identify the functional 
groups present. IR was not time consuming and was fast. Polarimetry was used to 
help determine the angle of rotation for each chiral compound. Polarimetry was also 
fast and easy to use. 
 
5. Conclusion 
It can be concluded that the approach taken for this project provided an array of tech-
niques for the isolation and characterisation of the compounds isolated from the husks 
of C. megalocarpus. The tyrosinase inhibition assay determined that the ethyl acetate 
extract of croton vinegar oil had the highest inhibition rate of 59.33%. This gives an 
indication that the ethyl acetate extract of croton vinegar oil is suitable for further work 
as it may play a vital role for the cosmetics and beauty industry for skin lightening or 
skin care as a melanin suppressor. CellTiter assay revealed that the dichloromethane 
extract of husks showed a cell viability of 45% and indicates that its potential to be 
able to kill FM-55 melanoma cells may also be effective in killing other types of cancer 
cells such as CaCo-2, Hela and MCF-7. This study has also shown that the 
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compounds isolated from the husks of C. megalocarpus have a relatively low toxicity 
(as determined by tyrosinase inhibition assay) and is safe to handle.  
However, as the isolated compounds were derived from the dichloromethane extract, 
it can also be concluded that the compounds may be synergistic as the dichloro-
methane extract showed a cell viability of 45%. This study has shown the potential of 
C. megalocarpus to be studied for future research as its different types of diterpenoids 
and recognises the potential use of the husks. The husks are shown to be promising 
as diterpenoids have been extracted, isolated and tested for cytotoxicity and anti-can-
cer properties and these findings would enable EFK to begin utilising the husks instead 
of throwing away after the de-husking process. 
6. Further work 
The outcome for the investigation of the husks of C. megalocarpus appears it to be an 
area of interest for future work. The bioassays consisted of the CellTiter assay and 
mushroom tyrosinase inhibition that tested for anti-melanogenic and toxicity proper-
ties. The melanin assay and yeast inhibition would have given a dynamic and varied 
characteristic of the compounds and extracts and would be suitable for the continua-
tion of the project. The melanin assay will be more cell-based work and will involve 
direct interaction with melanocytes unlike the tyrosinase assay which is non cell based.  
The melanin and tyrosinase assay are inter-related and would have provided a more 
in-depth analysis and profiling of the compounds and extracts. The yeast inhibition 
assay is an additional characteristic on which compounds and extract is able to kill 
yeast cells. This may provide alternative methods for treating people that have a yeast 
infection such as the overuse of antibiotic and general infections that occur due to high 
amount of yeast production in the body. Other cell viability assays such as neutral red 
and PrestoBlue may produce a varied approach to the CellTiter assay. Analysing the 
compounds of the methanol extract of husks of C. megalocarpus as similar com-
pounds may be extracted and isolated to the dichloromethane extract.   
 
 
 
 
59 
 
7. References 
Addae-Mensah, I., H. Achenbach, G.N. Thoithi, R. Waibel and W.J. Mwangi, (1991). 
A new triterpenoid from Croton megalocarpus. Planta Med., 57: A66-A67.  
Addae-Mensah, I., H. Achenbach, G.N. Thoithi, R. Waibel and J.W. Mwangi, (1992). 
Epoxychiromodine and other constituents of Croton megalocarpus. Phytochemistry, 
31: 2055-2058.  
Addae-Mensah, I., R. Waibel, H. Achenbach, G. Muriuki, C. Pearce and J.K. Sanders, 
(1989). A clerodane diterpene and other constituents of Croton megalocarpus. Phyto-
chemistry, 28: 2759-2761.  
Aldhaher, A., Langat, M., Ndunda, B., Chirchir, D., Midiwo, J., Njue, A., Schwikkard, 
S., Carew, M. and Mulholland, D., (2017). Diterpenoids from the roots of Croton di-
chogamus Pax. Phytochemistry, [online] 144, pp.1-8.  
Alfred Maroyi, (2017). Croton megalocarpus Hutch. in Tropical Africa: Phytochemistry, 
Pharmacology and Medicinal Potential. Research Journal of Medicinal Plants, 11: 
124-133.  
Aljancic, I.; Macura, S.; Juranic, N.; Andjelkovic, S.; Randjelovic, N.; Milosavljevic, S. 
Diterpenes from Achillea clypeolata. Phytochemistry (1996), 43, 169–171.  
Alqahtani, A. (2015). Phytochemical investigation of members of the asparagaceae 
and Euphorbiaceae families. Ph.D. Surrey University.  
Bai, D., Chen, Q., Chai, Y., Ren, T., Huang, C., Ingram, I.D.V., North, M., Zheng, Q. 
Xie, H. (2018). Vanillin derived a carbonate dialdehyde and a carbonate diol : novel 
platform monomers for sustainable polymers synthesis. RSC Advances. pp. 34297-
34303.  
Barltrop, J.A. et al. (1991) 5-(3-carboxymethoxyphenyl)-2-(4,5-dimenthylthiazoly)-3-
(4-sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethyl-
thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble 
formazans as cell-viability indicators. Bioorg. Med. Chem. Lett. 1, 611–4. 
Bevan, C., Ekong, D. and Okogun, J., (1968). West African timbers. Part XXI. Extrac-
tives from Daniellia species. The structure of a new diterpene, ozic acid. Journal of the 
Chemical Society C: Organic, p.1063. 
Bussmann, R. (2006). Ethnobotany of the Samburu of Mt. Nyiru, South Turkana, 
Kenya. Journal of Ethnobiology and Ethnomedicine, 2 pp.1-5.  
Cancer Research UK. (2019). Worldwide cancer statistics. [online] - https://www.can-
cerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer 
Chatatikun, M., Yamauchi, T., Yamasaki, K., Aiba, S. and Chiabchalard, A. (2017). 
Anti-melanogenic effect of Croton roxburghii and Croton sublyratus leaves in α-MSH 
stimulated B16F10 cells. Journal of Traditional and Complementary Medicine, [online] 
9(1), pp.66-72.  
60 
 
Chhonker, Y., Haney, S., Bala, V., Holstein, S. and Murry, D., (2018). Simultaneous 
Quantitation of Isoprenoid Pyrophosphates in Plasma and Cancer Cells Using LC-
MS/MS. Molecules, 23(12), p.1-10.  
Colović, M. B., Krstić, D. Z., Lazarević-Pašti, T. D., Bondžić, A. M., & Vasić, V. M. 
(2013). Acetylcholinesterase inhibitors: pharmacology and toxicology. Current neuro-
pharmacology, 11(3), p.315–335. https://doi.org/10.2174/1570159X11311030006   
Dictionary of Natural Products - http://dnp.chemnetbase.com/HelpFiles/DNP_Intro-
duction.pdf 
Dlova, N., Hamed, S., Tsoka-Gwegweni, J. and Grobler, A., (2015). Skin lightening 
practices: an epidemiological study of South African women of African and Indian an-
cestries. British Journal of Dermatology, [online] 173, pp.2-9. 
 Du, J., Wang, M., Chen, R. and Yu, D., (2001). Two new bislabdane-type diterpenoids 
and three new diterpenoids from the roots of Cunninghamia lanceolata. Planta Medica. 
67 (6), 542-547.  
Fratkin, E., (1996). Traditional medicine and concepts of healing among Samburu pas-
toralists of Kenya. J. Ethnobiol., 16: 63-98. 
Harinantenaina, L., Takahara, Y., Nishizawa, T., Kohchi, C., Soma, G. I., Asakawa, 
Y., (2006). Chemical constituents of Malagasy liverworts, Part V: prenyl bibenzyls and 
clerodane diterpenoids with nitric oxide inhibitory activity from Radula appressa and 
Thysananthus spathulistipus. Chemical & Pharmaceutical Bulletin 54, 1046-1049.  
hin, J. and Park, K., (2014). Current clinical use of depigmenting agents. Dermatolog-
ica Sinica, [online] 32(4), pp.205-210.  
Iwagawa, T., Nakamura, S., Okamura, H. and Nakatani, M., (1996). Ichthyotoxic 
cembranoids from the Soft Coral, Sarcophyton sp. Bulletin of the Chemical Society of 
Japan. 69 (12), 3543-3549.  
Jian, B., Zhang, H., Han, C. and Liu, J. (2018). Anti-Cancer Activities of Diterpenoids 
Derived from Euphorbia fischeriana Steud. Molecules, [online] 23(2), p.387.  
Johns, T., Mhoro, E., Sanaya, P. and Kimanani, E., (1994). Herbal remedies of the 
Batemi of Ngorongoro District, Tanzania: a quantitative appraisal. Economic Botany, 
48(1), pp.90-95.  
Kafuku, G. and Mbarawa, M., (2010). Biodiesel production from Croton megalocarpus 
oil and its process optimization. Fuel, 89(9), pp.2556-2560.  
Kariuki, D. (2017). Croton plant offers some hope for biofuel enthusiasts | Cleanleap. 
[online] Cleanleap.com.  
Kew Plant Database (2012) http://epic.kew.org/index.htm – Figure 2  
Kibet, J., Mosonik, B., Nyamori, V. and Ngari, S., 2018. Free radicals and ultrafine 
particulate emissions from the co-pyrolysis of Croton megalocarpus biodiesel and fos-
sil diesel. Chemistry Central Journal, 12(1), pp.1-5.  
61 
 
Kokwaro, J., (2009). Medicinal Plants of East Africa. 3rd Edn., University Press, Nai-
robi. p.1-10 
Langat, M., Crouch, N., Smith, P. and Mulholland, D., (2011). Cembranolides from the 
Leaves of Croton gratissimus. Journal of Natural Products, 74(11), pp.1-7.  
Leakey, R., Temu, A. and Vantomme, P. (1996). Domestication and commercializa-
tion of non-timber forest products in agroforestry systems. 9th ed. [ebook] pp.236-243.  
Lopes, L. M. X.; Bolzani, V. D. S.; Trevisan, L. M. V.; Grigolli, T. M. Terpenes from 
Aristolochia triangularis. Phytochemistry (1990), 29, 660–662. 
Macmillan.org.uk. (2019). Docetaxel. [online] -https://www.macmillan.org.uk/infor-
mation 
 
Maroyi, A., (2010). Croton megalocarpus Hutch. [Internet] Record from PROTA4U. 
Lemmens, R.H.M.J., Louppe, D. & Oteng-Amoako, A.A. (Editors). PROTA (Plant Re-
sources of Tropical Africa / Ressources végétales de l’Afrique tropicale), Wageningen, 
Netherlands.   
Mfotie Njoya, E., Eloff, J. and McGaw, L., (2018). Croton gratissimus leaf extracts in-
hibit cancer cell growth by inducing caspase 3/7 activation with additional anti-inflam-
matory and antioxidant activities. BMC Complementary and Alternative Medicine, 
18(1). p.1-8. 
Mukonyi, K. W. and Ndiege, I. O. 2-Hydroxy-4-methoxybenzaldehyde: aromatic taste 
modifying compound from Mondia whytei skeels. Bull. Chem. Soc. Ethiop. (2001), 
15(2), 137-141. 
Mulholland, D.A., Langat, M.K., Crouch, N.R., Coley, H.M., Mutambi, E.M. and 
Nuzillard, J.-M. (2010). Cembranolides from the stem bark of the southern African 
medicinal plant, Croton gratissimus (Euphorbiaceae). Phytochemistry, 71(11–12), 
pp.1-6.  
natural, G., (2020). Focus On Skin Lightening And Whitening. [online] Becarre-natu-
ral.com.  
Ndhlala, A. R., Aderogba, M. A., Ncube, B., & Van Staden, J. (2013). Anti-oxidative 
and cholinesterase inhibitory effects of leaf extracts and their isolated compounds 
from two closely related Croton species. Molecules (Basel, Switzerland), 18(2), 
1916–1932. https://doi.org/10.3390/molecules18021916   
Ndunda, B., Langat, M., Mulholland, D., Eastman, H., Jacob, M., Khan, S., Walker, L., 
Muhammad, I., Kerubo, L. and Midiwo, J., (2016). New ent-Clerodane and Abietane 
Diterpenoids from the Roots of Kenyan Croton megalocarpoides Friis & M. G. Gil-
bert. Planta Medica, [online] 82(11/12), pp.1079-1086. 
Nyawira Muchane, M., (2019). Population Status, Distribution Patterns and Conserva-
tion Needs of Endangered &lt;i&gt;Croton alienus&lt;/i&gt; Pax in Kenya. International 
Journal of Natural Resource Ecology and Management, [online] 4(5), p.120.  
62 
 
Pavia, D., Lampman, G., Kriz, G. and Vyvyan, J., (2009). Introduction To Spectros-
copy. 4th ed. Washington: Pavia L Donald, p.84. 
Riss, T., Moravec, R., Niles, A., Duellman, S., Benink, H., Worzella, T. and Minor, L., 
(2013). Cell Viability Assays. [online] Ncbi.nlm.nih.gov.  
Salatino, A., Salatino, M. and Negri, G. (2007). Traditional uses, chemistry and phar-
macology of Croton species (Euphorbiaceae). [online] SciELO.  
Secorun, L., 2020. 'This Is Our Future' – Kenya's Croton Tree Touted As New Biofuels 
Crop. [online] the Guardian. Available at: https://www.theguardian.com/sustainable-
business/2017/jan/10/croton-oil-biofuels-kenya-food-security-farming-africa  
Shahbazi-Gahrouei, D., Arab-Bafrani, Z., Abbasian, M. and Fesharaki, M., (2016). 
Multiple MTS assay as the alternative method to determine survival fraction of the 
irradiated HT-29 colon cancer cells. Journal of Medical Signals & Sensors, [online] 
6(2), p.112. 
Shin, J. and Park, K., (2014). Current clinical use of depigmenting agents. Dermato-
logica Sinica, 32(4), pp.205-210. 
van Zandvoort, I., Koers, E., Weingarth, M., Bruijnincx, P., Baldus, M. and Weck-
huysen, B., (2015). Structural characterization of 13C-enriched humins and alkali-
treated 13C humins by 2D solid-state NMR. Green Chemistry, 17(8), pp.4383-4392. 
Wong, M., Lao, X., Ho, K., Goggins, W. and Tse, S. (2017). Incidence and mortality of 
lung cancer: global trends and association with socioeconomic status. Scientific Re-
ports, [online] 7(1). p.1-9. 
World Health Organization. (2019). Breast cancer: prevention and control. [online] - 
https://www.who.int/cancer/detection/breastcancer/en/index1.html 
Wu, D., Roskilly, A. P., & Yu, H. (2013). Croton megalocarpus oil-fired micro-trigener-
ation prototype for remote and self-contained applications: experimental assessment 
of its performance and gaseous and particulate emissions. Interface focus, 3(1), p.1-
10. 
Xu, W., Liu, W. and Liang, Q., (2018). Chemical Constituents from Croton Species 
and Their Biological Activities. Molecules, [online] 23(9), p.2333. Available at: 
<https://www.mdpi.com/1420-3049/23/9/2333>. 
Yusuf, M., Mahmoud, N., Rirash, F., Stoff, B., Liu, Y. and McMichael, J., (2019). Skin 
lightening practices, beliefs, and self-reported adverse effects among female health 
science students in Borama, Somaliland: A cross-sectional survey. International Jour-
nal of Women's Dermatology, [online] 5(5), pp.349-355.  
 
 
 
 
63 
 
8. Appendices 
 
 
Pt-1 1 2 3 4 5 6 7 8 9 10 11 12 
A L-Ty + Kojic 
Blank Buffer 
L-Ty + Kojic + 
Enzyme 
L-Ty + 
Methanol 
crude ex-
tract +  
Buffer 
L-Ty + 
Methanol 
crude ex-
tract + 
Enzyme 
L-Ty + 
CVO + 
Buffer 
L-Ty + 
CVO + 
Enzyme 
      
B       
C       
 
D 
      
E L-Ty + DMSO 
Blank Buffer  
L-Ty + DMSO 
+ Enzyme 
          
F           
G           
H           
 
 
 
 
 
Hexane 
Crude 
Extract 
Husk 
Hexane 
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Extract 
Husk 
(mouldy) 
Hexane 
Crude 
Extract 
F Cake 
Hex-
ane 
Crude 
Extract 
Seed 
Hexane 
Crude 
Extract 
Seed 
Oil 
DCM 
Crude 
Extract 
Husks 
DCM 
Crude 
Extract 
(mouldy) 
DCM 
Crude 
Extract 
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DCM 
Crude 
Ex-
tract 
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Croton 
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(DCM 
Ex-
tract) 
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Extract 
Husks 
Meth-
anol 
Crude 
Ex-
tract 
F 
Cake 
            
            
            
            
            
            
            
Methanol 
Crude 
Extract 
Seed 
Ozic 
Acid 
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A 
Epoxychiromodine Lavix 
Deudua 
Resin 
Croton 
Vinegar 
Oil 
(Ethyl 
Acetate 
Extract) 
Magnoflorine DMSO Etoposide 
         
         
         
         
         
Appendix A: Tyrosinase Inhibition Assay Template 
 
Appendix B: Plate 1 – CellTiter 96 Well Plate Template 
 
Appendix B1: Plate 2 - CellTiter on 96 Well Plate Order of Compounds and Extracts Template 
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A 50µg/ml           
B 25µg/ml           
C 12.5µg/ml           
D 6µg/ml           
E 50µg/ml           
F 25µg/ml           
G 12.5µg/ml           
H 6µg/ml           
 50µg/ml 25µg/ml 12.5µg/ml 6µg/ml 
 df T P df T p df T p df T p 
S1 2 19.94 **0.0025 2 29.79 **0.0011 2 29.11 **0.0012 2 24.47 **0.0017 
S2 2 8.202 *0.0145 2 14.49 **0.0047 2 21.45 **0.0022 2 18.17 **0.0030 
S3 2 6.788 *0.0210 2 12.11 **0.0067 2 14.42 **0.0048 2 9.316 *0.0113 
S4 2 28.96 **0.0012 2 12.94 **0.0059 2 10.51 **0.0089 2 7.729 *0.0163 
S5 2 8.736 *0.0129 2 10.83 **0.0084 2 10.29 **0.0093 2 6.436 *0.0233 
S6 2 8.231 *0.0144 2 8.677 *0.0130 2 10.93 **0.0083 2 7.715 *0.0164 
S7 2 8.565 *0.0134 2 11.53 **0.0074 2 10.27 **0.0094 2 7.398 *0.0178 
S8 2 7.387 *0.0178 2 9.799 *0.0103 2 12.66 **0.0062 2 8.044 *0.0151 
S9 2 6.813 *0.0209 2 10.11 **0.0096 2 11.32 **0.0077 2 7.214 *0.0187 
Appendix C: CellTiter on 96 Well Plate Dilutions of Different Concentrations Template 
 
Appendix D: T test analysis of compounds/extracts of CellTiter MTS Assay 
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S1
0 
2 7.217 *0.0187 2 8.445 *0.0137 2 19.47 **0.0026 2 9.946 *0.0100 
S1
1 
2 15.22 **0.0043 2 14.08 **0.0050 2 15.89 **0.0039 2 15.41 **0.0042 
S1
2 
2 28.27 **0.0012 2 13.28 **0.0056 2 29.07 **0.0012 2 47.59 ***0.0004 
S1
3 
2 15.42 **0.0042 2 13.91 **0.0051 2 15.81 **0.0040 2 105.9 ****<0.00
01 
S1
4 
2 10.44 **0.0091 2 11.87 **0.0070 2 12.12 **0.0067 2 21.58 **0.0021 
S1
5 
2 6.680 *0.0217 2 14.87 **0.0045 2 16.01 **0.0039 2 15.63 **0.0041 
S1
6 
2 6.450 *0.0232 2 13.35 **0.0056 2 8.784 *0.0127 2 11.01 **0.0082 
S1
7 
2 7.044 *0.0196 2 7.244 *0.0185 2 29.40 **0.0012 2 15.54 **0.0041 
S1
8 
2 9.401 *0.0111 2 15.59 **0.0041 2 34.23 ***0.0009 2 13.37 **0.0056 
S1
9 
2 6.841 *0.0207 2 9.249 *0.0115 2 16.10 **0.0038 2 13.74 **0.0053 
Et
op
os
id
e 
2 28.27 **0.0012 2 4.424 *0.0475 2 6.075 *0.0260 2 15.25 **0.0043 
D
M
S
O 
2 15.42 **0.0042 2 10.55 **0.0089 2 9.960 **0.0099 2 27.71 **0.0013 
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Appendix E1- Trans ozic acid 
Appendix E: IR spectra of isolated compounds: trans ozic acid, sartone A, epoxykaurane, 
epoxychiromodine, (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 7E,11Z-trien-20,10-olide, (-)-
(1S*,4S*,10R*)-1,4- dihydroxycembra-2E,7E,11Z-trien-20,10-olide and vanillin 
Appendix E2- Sartone A 
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Sartone A 
Appendix E3- Epoxykaurane 
Appendix E4- Epoxychiromodine 
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Appendix E5- Vanillin 
Appendix E6- (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 7E,11Z-trien-20,10-olide 
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Appendix E7 (-)-(1S*,4S*,10R*)-1,4- dihydroxycembra-2E,7E,11Z-trien-20,10-olide 
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Appendix F: Processed 1H and 13C of the seven isolated compounds of the husks of C. megalo-
carpus: Ent-16S,17-epoxykaurane, Trans ozic acid, sartone A, epoxychiromodine, (+)-
[1R*,4S*,10R*]-4-hydroxycembra-2E, 7E,11Z-trien-20,10-olide, (-)-(1S*,4S*,10R*)-1,4- dihydroxy-
cembra-2E,7E,11Z-trien-20,10-olide and vanillin. 
 
1H NMR for Compound 56: Ent-16S,17-epoxykaurane 
13C NMR for Compound 56: Ent-16S,17-epoxykaurane 
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1H NMR for Compound 58: Trans ozic acid 
13C NMR for Compound 58: Trans ozic acid 
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1H NMR for Compound 60: Sartone A 
13C NMR for Compound 60: Sartone A 
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1H NMR for Compound 19: Epoxychiromodine 
13C NMR for Compound 19: Epoxychiromodine 
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1H NMR for Compound 5: (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 7E,11Z-trien-20,10-olide 
13C NMR for Compound 5: (+)-[1R*,4S*,10R*]-4-hydroxycembra-2E, 7E,11Z-trien-20,10-olide 
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13C NMR for Compound 7: (-)-(1S*,4S*,10R*)-1,4- dihydroxycembra-2E,7E,11Z-trien-20,10-olide 
1H NMR for Compound 7: (-)-(1S*,4S*,10R*)-1,4- dihydroxycembra-2E,7E,11Z-trien-20,10-olide 
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1H NMR for Compound 59: Vanillin 
